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Objectives 
The primary objective of this diploma thesis was the heterologous, recombinant 
expression of two human enzymes and their purification. Recombinant RNase ZS and 
RNase ZL had to be expressed in Escherichia coli and purified to near homogeneity 
in order to use them as parts of an in vitro tRNA-processing system for the study of 
pathogenic mutations of mitochondrial tRNAs. Furthermore, the human enzyme tRNA 
ribonucleotidyl transferase had to be produced in the same way and for the same 
purpose. 
A secondary objective was the analysis of the quaternary structure of the RNase Z 
isoforms. Experiments on purified RNase ZL should show, if this enzyme is active as 
monomer or homodimer. 
Ziele 
Primäres Ziel dieser Diplomarbeit war die heterologe Expression zweier 
rekombinanter, humaner Enzyme und deren Reinigung. Rekombinante RNase ZS 
und RNase ZL sollten in Escherichia coli exprimiert und fast bis zur Homogenität 
gereinigt werden, um sie als Teile eines in vitro tRNA-Prozessierungssystems zu 
verwenden, mit welchem pathogene Mutationen mitochondrialer tRNAs erforscht 
werden sollen. Darüber hinaus sollte das humane Enzym tRNA-
Ribonukleotidyltransferase auf dieselbe Weise und zum selben Zweck produziert 
werden. 
Sekundäres Ziel war die Analyse der Quartärstruktur der beiden RNase Z-Isoformen. 
Experimente an gereinigter RNase ZL sollten zeigen, ob dieses Enzym als Monomer 
oder Homodimer aktiv ist. 
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Introduction to tRNA-processing 
Structure and Function of tRNAs 
In all organisms the process of ribosomal protein synthesis requires transfer RNA 
(tRNA) molecules as adaptors between messenger RNAs (mRNA) and peptide bond 
formation. A tRNA is specific for one type of amino acid, which is covalently linked to 
its 3’ end. Within a loop on the opposite side the tRNA contains the anticodon: three 
nucleotides, whose sequences are specific for the amino acid. The anticodon 
enables the tRNA to recognize the complementary codon on the mRNA by means of 
base pairing within the ribosome. As a consequence the amino acid is able to 
perform a nucleophilic attack on the activated carboxyl, which connects the growing 
polypeptide chain with the previous tRNA, thus forming a peptide bond through the 
action of the ribosome. Then the previous tRNA is released from the ribosome and 
can be reloaded with an amino acid by its aminoacyl tRNA synthetase. 
Transfer RNAs are small RNA molecules, whose length is between 50 and 105 bp 
(usually about 80 bp). Intramolecular base pairing results in the typical secondary 
structure, as shown below for an aminoacylated phenylalanine tRNA (Figure 1A). The 
secondary structure comprises the 5’ end, the D loop, the anticodon loop, the 
variable V loop, the T loop, also called “TΨC loop”, and the 3’ end or “acceptor end” 
with the terminal, invariant CCA sequence following the so called “discriminator 
nucleotide”, in a typical clover leaf structure. The tertiary structure shows a compact, 
L-shaped tRNA in two different orientations (Figure 1B and 1C). The anticodon loop 
is on the long end of the L, whereas the acceptor stem is on the short end of the L. In 
contrast to the secondary structure the T and D loop are rather close to each other in 
the tertiary structure. Below the outlines of the secondary and tertiary structure the 
primary structure is shown for this phenylalanyl tRNA (Figure 1D). The primary 
structure also gives a good survey of the many modified nucleotides in tRNAs. 
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Figure 1. Primary (D), secondary (A) and tertiary (B and C) structure of a tRNA. Posttranscriptionally 
modified nucleotides: pseudouridine (“Ψ”), dihydrouridine (“D”), wyosine (“Y”) and ribothymidine (“T”). 
See text for further details and comments. 
(taken from http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/mboc4/ch6f52.gif) 
Biosynthesis of tRNAs 
Transfer RNAs are transcribed as precursors: they contain 5’ leader and 3’ trailer 
sequences. In order to get functional tRNAs these leaders and trailers have to be 
removed and the 3’ terminal CCA has to be added in those organisms, which lack a 
genetically encoded CCA (all eukaryotes, many bacteria and some archaea). First of 
all the 5’ leader sequence is removed by an endonuclease followed by the removal of 
the 3’ trailer by an endonuclease or by endo- and exonucleases. Next the terminal 
CCA sequence is added by another enzyme in organisms, whose tRNA genes do not 
genetically encode the CCA. All these enzymes recognize tRNAs by their tertiary 
structure and by interacting only with their sugar-phosphate backbones. Since these 
enzymes do not bind tRNAs in a sequence-specific way, they work on every tRNA in 
one organism. Then introns are spliced, which occurs in some tRNAs of most 
eukaryotes and some archaea. Finally many nucleotides are chemically modified 
(“posttranscriptionally modified nucleotides”) (Hopper and Phizicky 2003). 
Generation of mature 5’ ends 
After transcription all tRNAs contain 5’ leader and 3’ trailer sequences, which have to 
be removed in order to obtain functional tRNAs. First the 5’ leader sequence is 
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removed by an enzyme called RNase P, which has been found in organisms from all 
three domains of life. This enzyme consists of one to ten protein subunits (1 in 
bacteria, 4 in archaea, 9 or 10 in eukarya) and an RNA. Therefore RNase P is a 
ribonucleoprotein and the RNA component shows - at least in vitro - basic catalytic 
activity (Willkomm and Hartmann 2007) (Kikovska, Svärd et al. 2007). However, it 
has been demonstrated recently that at least human mitochondrial RNase P does not 
need a trans-acting RNA in order to perform its catalysis and that this enzyme is 
composed of protein only (Holzmann, Frank et al. 2008). 
RNase P is an endonuclease dependent on divalent metal ions. Its catalytic activity is 
the hydrolysis of phosphodiester bonds in precursor tRNAs leaving a phosphate on 
the tRNA, thus creating mature 5’ ends by removing the 5’ leader sequence (Figure 
2) (Kazantsev and Pace 2006). 
 
Figure 2. Catalytic activity of RNase P. Removal of 5’ leader sequence from pre-tRNA (a) and 
mechanism of hydrolytic cleavage reaction (b). 
(taken from (Kazantsev and Pace 2006)) 
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Generation of mature 3’ ends 
The next step to gain functional tRNA is the removal of the 3’ trailer. Among the 
organisms studied so far there are two pathways to achieve this: in the 
“exonucleolytic” pathway the precursor-tRNA is endonucleolytically cut downstream 
and trimmed to its mature 3’ end by exonucleases. Only a single endonucleolytic cut 
is needed in the “endonucleolytic” pathway, which is then performed by an enzyme 
called RNase Z (Figure 3). Both pathways sometimes coexist in organisms: 
apparently they serve as backup systems for each other and/or involved enzymes 
have other functions as well (Redko, Li de la Sierra-Gallay et al. 2007). 
 
Figure 3. Exonucleolytic (a) and endonucleolytic (b) pathway for creating mature 3’ ends of tRNAs. 
Endonucleases are shown as scissors, whereas exonucleases are depicted by a “pacman” symbol. 
(taken from (Redko, Li de la Sierra-Gallay et al. 2007)) 
Many bacteria as well as all archaea and eukaryotes sequenced so far contain at 
least one copy of an orthologous RNase Z gene (Späth, Canino et al. 2007). This 
enzyme belongs to the family of zinc-dependent metallo-hydrolases, which is part of 
the β-lactamase superfamily (Redko, Li de la Sierra-Gallay et al. 2007). There are 
two isoforms of RNase Z: a long one of 750 to 930 amino acids depending on the 
organism, called RNase ZL, which can only be found in eukaryotes, and a short one 
between 280 and 360 amino acids, called RNase ZS, which exists in organisms of all 
three domains of life. Based on structural studies it is assumed that the long form 
originated from the short form by gene duplication, hence that RNase ZS and RNase 
ZL are paralogues (Späth, Canino et al. 2007). 
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Typical structural features of RNase Z are (Figure 4): the “His motif” or “HxHxDH 
motif” is a conserved sequence motif serving for metal coordination in the active site. 
The “flexible arm” or “exosite” participates in binding of substrate but is outside the 
active site. Other features are targeting signals for mitochondria or chloroplasts and 
the “pseudo His-motif” or “Ψ-His-motif”, a degenerated His-motif without the ability to 
coordinate metal ions, present only in eukaryal RNase ZL (Vogel, Schilling et al. 
2005). 
 
Figure 4. Domains of RNase Z. Abbrevations explained above except for “Mito signal”, which is a 
mitochondrial targeting signal. 
(taken from (Redko, Li de la Sierra-Gallay et al. 2007)) 
The crystal structures of RNase ZS enzymes from Bacillus subtilis, Escherichia coli 
and Thermotoga maritima form homodimers, which is therefore assumed to be true 
for all other orthologous RNase ZS enzymes (Ceballos and Vioque 2007). RNase ZL, 
on the other hand, is generally assumed to be a monomer due to its domain 
structure, which seems to resemble a covalently linked dimer (Figure 4). However, no 
experimental data have been published so far concerning the quaternary structure of 
RNase ZL. 
RNase Z is an endonuclease, which catalyses cleavage of the 3’ trailer from the 
precursor tRNA by hydrolysis of a phosphodiester bond. A 5’ phosphate is left on the 
trailer and a 3’-hydroxyl group remains on the tRNA (Vogel, Schilling et al. 2005). The 
proposed mechanism for this hydrolysis comprises two initial steps (Figure 5): firstly, 
the phosphate group, which connects the last nucleotide of the tRNA with the first 
nucleotide of the 3’ trailer, is polarized by two zinc ions (as for RNase ZS from 
Bacillus subtilis). Secondly, a water molecule (“water147” in Figure 5c) is 
deprotonated by an aspartic acid residue (“D67”). As a result, this hydroxyl ion 
performs a nucleophilic attack on the polarized phosphate, whereupon a proton is 
regained from a nearby located water molecule (“wat5”) (Li de la Sierra-Gallay, 
Pellegrini et al. 2005). 
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Figure 5. Active site (b) and mechanism of hydrolytic cleavage reaction (c) of RNase ZS (B. subtilis). 
Nitrogen atoms of histidine residues in blue, oxygen atoms of aspartate in red. Zn ions depicted as 
yellow spheres, water molecules as grey spheres. tRNA shown in green. 
(taken from (Redko, Li de la Sierra-Gallay et al. 2007)) 
If a tRNA is processed by RNase Z (endonucleolytic pathway) and if its terminal CCA 
is not genetically encoded, cleavage will usually occur 3’ to the discriminator 
nucleotide and the CCA will have to be added by an enzyme called tRNA nucleotidyl 
transferase. In Homo sapiens and many other organisms maturation of 3’ ends of 
tRNAs is believed to work that way (RNase Z + tRNA ribonucleotidyl transferase). 
Aside from processing tRNAs there are other functions assumed for RNase Z, some 
of which have been discovered in several organisms. There are three reasons for this 
assumption: firstly, RNase Z is present in Escherichia coli, whose tRNAs are 
processed by the exonucleolytic pathway. Secondly, RNase Z is essential in 
Saccharomyces cerevisiae, although its tRNA maturation can be backed up by the 
exonucleolytic pathway. Thirdly, RNase Z has been shown to cleave other substrates 
as well in vitro (Vogel, Schilling et al. 2005). 
Mutations in the gene for human RNase ZL (called “ELAC2”, whereas the gene for 
RNase ZS is called “ELAC1”) located at chromosome 17p are suspected to be linked 
to prostate cancer in humans. Therefore, ELAC2 is known as “candidate prostate 
cancer susceptibility gene” (Takaku, Minagawa et al. 2003). 
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Addition of terminal CCA 
All tRNAs have the same invariant sequence at their 3’ end on the acceptor stem: 
CCA. These three nucleotides can either be encoded genetically or added post-
transcriptionally by an enzyme called tRNA ribonucleotidyl transferase (name of 
corresponding human gene: “TRNT1”). This enzyme is also responsible for repair of 
the CCA-sequence and can therefore be found in all organisms (Augustin, Reichert 
et al. 2003). 
In contrast to other polymerases tRNA ribonucleotidyl transferases, also called CCA-
adding enzymes or CCases, do not use nucleic acid templates to incorporate the 
correct nucleotides, but mimic the normal Watson-Crick hydrogen bonding in two 
different ways: Archaeal class I CCA-adding enzymes use a combination of hydrogen 
bonds from amino acid sidechains and backbone phosphate groups of the tRNA to 
select the right nucleotide. Bacterial and eukaryal class II CCA-adding enzymes, on 
the other hand, perform this task solely by protein templating, which means hydrogen 
bonding with amino acid residues of the enzyme (Xiong and Steitz 2006). 
Human tRNA ribonucleotidyl transferase has a remarkable quaternary structure: it 
seems to form homodimers covalently linked by an intermolecular disulfide bond 
(Augustin, Reichert et al. 2003). 
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Technical introduction 
Expression via pET-System 
T7 RNA polymerase 
The pET-System (Novagen) is used for heterologous expression of recombinant 
proteins in Escherichia coli. This system is a so called “T7 expression system”, which 
means that the actual transcription of recombinant proteins is performed by T7 RNA 
polymerase. This enzyme originates from bacteriophage T7 and its advantages 
include high activity (~200 nucleotides per second at 37°C), selectivity for its own 
promoter (“T7 promoter”) without recognition of other promoters and having only one 
subunit of about 99 kDa, hence one gene. 
Regulation of target gene expression 
In order to start transcription and, as a result, translation of the recombinant protein, a 
source of T7 RNA polymerase and an appropriate T7 promoter in front of the actual 
target gene on the expression vector are necessary. The gene for T7 RNA 
polymerase is usually integrated in the chromosome of an appropriate expression 
host in a region derived from DE3 (Figure 6). This bacteriophage is a lambda 
derivative comprising the gene for the lac-repressor (“lac I”) and the gene for T7 RNA 
polymerase under the control of lacUV5 promoter. Therefore, such hosts are referred 
to as “DE3 lysogens”, abbreviated as “(DE3)”. The lacUV5 promoter contains the lac-
operator sequence, which serves as binding site for the lac-repressor. Quantitative 
transcription of T7 RNA polymerase is prevented by binding of repressor to operator, 
thus hampering bacterial RNA polymerase. Due to the ability of IPTG to bind to the 
lac-repressor, thereby inducing a conformational change, which keeps the repressor 
from binding to the lac-operator, transcription of T7 RNA polymerase is enabled by 
simply adding IPTG (Figure 6). 
As mentioned before, the target gene is under the control of a “T7lac promoter”, 
which is not only recognized by the T7 RNA polymerase but also contains a lac-
operator sequence to prevent transcription by basal levels of T7 RNA polymerase in 
the absence of IPTG. 
In addition to these control mechanisms there are some vectors in the pET series, 
which offer more stringent control of expression and some, which do not even have a 
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lac-operator in front of the target gene (“plain” T7 promoter). While a less tight control 
promotes protein production, more stringent regulation will protect Escherichia coli 
from possible toxic effects of recombinant proteins during growth. Therefore, the 
toxicity of recombinant protein has to be considered before choosing a pET 
expression vector on the basis of its control mechanism. 
 
Figure 6. IPTG inducible T7 expression system using a vector with T7lac promoter in front of the target 
gene. Lac-operator abbreviated as “lac o”. See text for details and comments. 
(taken from pET System manual (Novagen) with small modifications) 
Fusion tags 
In general, fusion tags are artificial polypeptides or natural proteins fused to proteins 
of interest in order to facilitate purification of these recombinant proteins by affinity 
chromatography, to enhance solubility, promote disulfide bond formation, allow 
detection via Western blot or even enable the export into the periplasm. Normally 
their sequences are fused to 5’ or 3’ ends of target genes resulting in N- or C-terminal 
tags, but internal tags are possible as well. After purification many tags can be 
removed from the recombinant protein by special proteases. Since all pET 
expression vectors encode one or more N- or C-terminal fusion tags, the need for 
one or the other tag should be considered carefully, when choosing a vector. 
  17 
pET expression vector 
The Novagen pET System Manual distinguishes between transcription and 
translation vectors. Transcription vectors lack the sequence of a ribosome binding 
site in contrast to translation vectors, which encode the ribosome binding site from a 
gene of phage T7. 
Other general features of an expression vector are: origin of replication, selective 
marker (usually an antibiotic resistance gene) and multiple cloning site (contains 
multiple restriction sites), as can be seen in Figure 7. As mentioned below in the 
section “Materials and Methods”, pET21b(+) was used as expression vector and 
therefore the vector map of the pET21 series is shown. This vector includes, apart 
from all the basic features as described above, an f1 origin for generation of single 
stranded plasmid DNA upon infection with a helper phage and the gene lac I, which 
codes for the lac-repressor. 
The solid black arrow in Figure 7 represents the part of the vector, where the target 
gene should be inserted and which is transcribed by T7 RNA polymerase upon 
induction by addition of IPTG. This region, called “cloning/expression region”, is 
shown in more detail in Figure 8 with all the features necessary for cloning (MCS), 
regulation (lac-operator as part of the “T7lac promoter”), transcription (T7 promoter, 
T7 terminator) and translation (ribosome binding site) as well as the tags (T7-tag, 
His-tag). It should be considered that the T7-tag can be removed from any pET21 
with the aid of Nde I (or Nhe I) and a second restriction endonuclease cutting in the 
MCS for cloning a gene into the vector. 
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Figure 7. Vector map of pET21a(+). According to Novagen 1bp needs to be subtracted from each site 
beyond BamHI at 198 to get the correct map of pET21b(+), which is 5442bp in length. See text for 
details and comments. 
(taken from http://www.emdbiosciences.com/html/NVG/home.html) 
 
Figure 8. Cloning/expression region of pET21a-d(+). 
(taken from http://www.emdbiosciences.com/html/NVG/home.html) 
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Expression via IMPACT system 
IMPACT (Intein mediated purification with an affinity chitin-binding tag, New England 
Biolabs) is a T7 expression system (see above), which utilizes a special tag. This tag 
consists of a chitin binding domain, which is used for affinity purification on a chitin 
column, and an intein domain (from Saccharomyces cerevisiae), whose self-cleavage 
activity upon induction by addition of thiols is used to elute the purified target protein 
from the column (Figure 9). 
 
Figure 9. IMPACT system. Affinity chromatography and differences between C- and N-terminal fusion 
tags therein are shown. See text for details and comments. 
(taken from IMPACT™-CN instruction manual, version 2.1, New England Biolabs) 
There are four vectors available: two coding for C- and two coding for N-terminal 
fusion tags. One of each kind gives rise to recombinant proteins, which contain 
additional amino acids between protein and intein tag for more efficient cleavage, 
whereas the others lack these additional nucleotides. If an N-terminal fusion tag is 
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chosen, a small (~1.6 kDa) secondary cleavage product will be eluted in the course 
of affinity chromatography. The lack of additional amino acids without subsequent 
treatment with proteases combined with a one-step purification procedure is unique 
and beneficial, if purified native recombinant protein is required. 
Purification via IMAC 
Immobilized metal ion affinity chromatography (“IMAC”) is a kind of affinity 
chromatography, which uses the affinity of amino acids to metal ions for separation 
purposes. Since histidines have a high affinity towards divalent metal cations, 
immobilized Ni2+ (or other divalent cations) can be used to bind histidine-tagged 
recombinant proteins, thus retaining them (Figure 10). These divalent metal cations 
are immobilized by chelating groups, which are coupled to the matrix (e.g. 
sepharose). Beads of this material are used as stationary phase in the course of 
affinity chromatography and chelated divalent cations are able to bind histidine-
tagged recombinant proteins (in the liquid mobile phase) by coordinate binding. 
Usually imidazole is used in excessive amounts for competitive elution: This molecule 
is able to coordinate the divalent metal cation just like the histidines, therefore 
replacing them, hence the whole protein. 
 
Figure 10. Immobilized metal ion affinity chromatography with hexahistidine-tagged protein. The eluent 
imidazole displaces the histidines in a competitive manner. 
(imidazole taken from http://www.bmrb.wisc.edu/metabolomics/standards/imidazole/lit/4744.png) 
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Analysis of quarternary structure 
Size exclusion chromatography 
Size exclusion chromatography is a chromatographic method, which separates 
molecules according to their size. When an aqueous solution is used as mobile 
phase, it is sometimes called “gel filtration chromatography”. 
The stationary phase consists of small polymer beads with many pores of different 
sizes and the molecules to be separated are dissolved in the liquid mobile phase. 
Whereas larger molecules can enter only large pores or none at all, if they are too 
big, smaller molecules are able to enter more pores or all, if they are too small. 
Therefore, small molecules have a longer distance to cover, thus elute later than 
larger ones (Figure 11). 
If gel filtration chromatography is performed with proteins under physiological 
conditions, they will elute according to their oligomeric state, whereupon monomers 
can be distinguished from dimers or oligomers. 
 
Figure 11. Separation mechanism of size exclusion chromatography. 
(taken from http://en.wikipedia.org/wiki/Image:SizeExChrom.png) 
Glycerol gradient centrifugation 
Glycerol gradient centrifugation (a kind of “rate zonal centrifugation”) is a method for 
determining the molecular mass or “size” of a molecule. A glycerol gradient is set up 
in a centrifugation tube and the sample (mixture of molecules with different molecular 
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masses) is added on top. After centrifugation molecules will be separated according 
to their molecular mass and density (Figure 12). 
If glycerol gradient centrifugation is performed with proteins under physiological 
conditions, they will sediment according to their oligomeric state, whereupon 
monomers can be distinguished from dimers or oligomers. 
 
Figure 12. Separation by rate zonal centrifugation (e. g. glycerol gradient centrifugation) according to 
molecular mass (“size”). 
Chemical cross-linking 
Chemical cross-linking is a method that chemically links two adjacent molecules 
(mostly polymers as well as biopolymers, e. g. proteins) by a covalent bond. Since 
cross-linking can only occur between adjacent molecules, this reaction is interpreted 
as evidence that the participating molecules are in close physical neighbourhood 
and/or interact with each other. If proteins under physiological conditions can be 
cross-linked, it will usually be assumed that they form dimers or oligomers depending 
on the size of the products. The impossibility of getting cross-linked, however, cannot 
be taken as reference that proteins are active as monomers. Cross-linked proteins 
can be analyzed by conventional SDS-PAGE, although gradient gels might be useful, 
if bands are not focused well enough. 
The reagents catalyzing this reaction are often classified according to the different 
functional groups they react with and according to the spacer they introduce. EDC, 
for example, is a zero-length (no spacer introduced between the cross-linked 
molecules), heterobifunctional (reacts with two different functional groups) cross-
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linking reagent coupling carboxyl groups to primary amines, whereas BS3 is a 
homobifunctional (reacts with two functional groups of the same kind), amine-reactive 
(reacts with primary amines) cross-linking reagent introducing an 8-carbon spacer. 
Blue native PAGE 
Blue native PAGE is a kind of polyacrylamide gel electrophoresis, in which proteins 
can be separated under native, not denaturing conditions (without SDS). Coomassie 
Brilliant Blue G250 is used for providing a uniform negative charge to proteins 
necessary for separation according to mass or “size” instead of isoelectric point. 
Therefore, dimers or oligomers should be visible as bands after staining of the gel. 
These bands correspond to masses approximately two or more times as high as their 
monomeric forms. Proteins of known molecular mass and quarternary structure are 
used as mass standards. 
As in chemical cross-linking, gradient gels might be useful, if bands are not focused 
well enough. 
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Materials and Methods 
Materials 
Buffers and solutions 
• 0.5x TBE: 44.5 mM Tris, 44.5 mM H3BO3, 1 mM EDTA 
• 5x Laemmli buffer: 300 mM Tris-Cl (pH 6.8), 60% glycerol, 10% SDS, 0.025% 
bromophenol blue, 7% 2-mercaptoethanol 
• LB: 0.5% yeast extract, 1% tryptone, 1% NaCl, pH 7 
• LB agar plates: 1.5% agar, 0.5% yeast extract, 1% tryptone, 1% NaCl, pH 7 
• M3: 210 mM mannitol, 70 mM sucrose, 20 mM Tris-Cl (pH 7.6), 10 mM KCl, 6 
mM EDTA 
• MS: 420 mM mannitol, 140 mM sucrose, 10 mM Tris-Cl (pH 7.6), 5 mM EDTA 
• PBS: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl, pH 7.4 
• PBST: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl, 0.3% Tween-20, pH 7.4 
• RSB: 10 mM Tris-Cl (pH 7.6), 10 mM NaCl, 1.5 mM CaCl2 
• SOB: 0.5% yeast extract, 2% tryptone, 0.5% NaCl, 2.5 mM KCl, 10 mM MgCl2, 
pH 7 
• SOC: 0.5% yeast extract, 2% tryptone, 0.5% NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 20 mM glucose, pH 7 
Bacterial strains (E. coli) 
DH5 served as host for cloning of newly ligated, recombinant plasmids. Its genotype 
includes, among others, knockouts in recA1 and endA1. Furthermore it has a high 
transformation efficiency and achieves a good plasmid output. 
Beside the general expression host BL21(DE3) some other expression hosts were 
used as well, all of which are λDE3 lysogens: Rosetta2(DE3) is basically a 
BL21(DE3), which contains a plasmid carrying additional genes for tRNAs. Since E. 
coli uses some codons less often compared to eukaryotes, the corresponding tRNAs 
are called “rare tRNAs”. By expressing higher levels of seven rare tRNAs 
Rosetta2(DE3) is adjusted to the eukaryotic codon usage, thus expression of 
eukaryotic genes is improved. The additional plasmid, called “pRARE2”, which 
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provides chloramphenicol restistance for selection, is compatible to all pET vector 
plasmids. 
A second derivative of BL21(DE3), ArcticExpress™(DE3), constitutively expresses 
two cold-adapted chaperonins (Cpn10 and Cpn60) from the psychrophilic bacterium 
Oleispira antarctica. This should decrease the formation of inclusion bodies and 
therefore enhance solubility of recombinant proteins in addition to expression at low 
temperatures (<15°C), which is generally thought to  improve solubility due to better 
folding properties. The genes for the chaperonins are located on an additional 
plasmid (provides gentamycin resistance for selection), which is compatible with all 
pET vector plasmids but not compatible with pRARE2, because they have the same 
origin of replication (P15a of pACYC). 
A new strain of ArcticExpress™(DE3) was created by transforming it with pRARE2 
isolated from Rosetta2(DE3) by Miniprep and amplified by DH5. This strain, called 
“AE-RARE(DE3)”, was only stable under permanent balancing selection with 
gentamycin and chloramphenicol, since the plasmid providing the additional 
chaperonins was not compatible with pRARE2. 
Vectors (plasmids) 
Among the vectors of the pET-System (Novagen) the translation vector pET21b(+) 
was chosen. It provides all the features necessary for replication (origin of 
replication), cloning (MCS), selection (ampicillin resistance gene), regulation (lac-
operator and lac-repressor gene), transcription (T7 promoter, T7 terminator) and 
translation (ribosome binding site) as well as two tags: an N-terminal T7-tag and a C-
terminal hexahistidine-tag (+ stop codon). The sequence of the T7-tag can be 
removed from the vector, if Nde I (or Nhe I) and a second restriction endonuclease 
cutting in the MCS are used for cloning a gene into the vector. Since there are no 
sequences for protease cleavage sites in the cloning/expression region of 
pET21b(+), both tags cannot be removed posttranslationally from the recombinant 
protein. 
In addition all four vectors of the IMPACT system (pTYB1, pTYB2, pTYB11 and 
pTYB12) were used for some basic experiments. They provide the same features as 
described above for pET21b(+), but have an intein-tag instead of a T7-tag or His-tag. 
This tag is either C-terminal (pTYB1 and pTYB2) or N-terminal (pTYB11 and 
pTYB12). Two vectors (pTYB2 and pTYB12) code for additional amino acids 
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between target protein and tag causing a more efficient intein-cleavage and two 
vectors (pTYB1 and pTYB11) do not code for additional amino acids resulting in 
native recombinant proteins without any extra residues. 
Substrates for enzyme assay 
Three different radiolabelled human pre-tRNAs were used for enzyme assays. These 
pre-tRNAs were endonucleolytically cleaved by RNase ZS or RNase ZL or elongated 
by tRNA ribonucleotidyl transferase in the course of the enzyme assays. Nuclear pre-
tRNAArg (“Arg2”: 3’trailer, no 5’ leader sequence) was used for enzyme assays with 
RNase ZS, mitochondrial pre-tRNATyr (“Y2”: 3’trailer, no 5’ leader sequence) was 
used for enzyme assays with RNase ZL and mitochondrial pre-tRNATyr (“Y6”: no 5’ 
leader and no 3’ trailer sequence, but no terminal CCA either) was used for enzyme 
assays with tRNA ribonucleotidyl transferase. The nucleotides ATP and CTP were 
added to the assays with tRNA ribonucleotidyl transferase. 
Methods 
Polymerase chain reaction for amplification of inserts 
PCRs were performed in 100 µl total volumes each and contained 0.2 mM dAGCT 
nucleotide mix, 10 ng template DNA, 0.5 µM oligonucleotide primers and 1.25 units 
Pfu Ultra™ DNA polymerase (Stratagene) in the reaction buffer supplied with the 
enzyme. 5% dimethyl sulfoxide was added to the reaction for amplification of ELAC2 
only. 
The initiation step was performed at 95°C for 60 se conds, cycling was repeated 35 
times and included: denaturation at 95°C for 15 sec onds, annealing at 58°C ( ELAC1) 
and 61°C ( ELAC2) respectively for 30 seconds, elongation at 72°C f or 150 seconds. 
Final elongation was done at 72°C for 10 minutes. 
Polymerase chain reaction for analyzing colonies 
Bacterial colonies were picked up and resuspended in 20 µl double distilled water. 
Half of each suspension was heated up to 95°C for 5  minutes and used as template 
for PCR, whereas the other half was stored at 4°C f or further use. 
PCRs were performed in 15 µl total volumes each and contained 0.2 mM dAGCU 
nucleotide mix, 1.5 µl of boiled E. coli as template, 0.5 µM oligonucleotide primers 
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and 0.19 units Taq DNA polymerase (LC) in the reaction buffer supplied with the 
enzyme. 
The initiation step was performed at 95°C for 60 se conds, cycling was repeated 35 
times and included: denaturation at 95°C for 15 sec onds, annealing at 58°C ( ELAC1) 
and 61°C ( ELAC2) respectively for 30 seconds, elongation at 72°C f or 50 seconds. 
Final elongation was done at 72°C for 200 seconds. 
Restriction control of DNA 
In order to control, whether purified plasmids met the expectations, they were 
restricted using 5 units of each restriction enzyme, mostly about 500 ng of DNA in a 
total volume of 10 µl. Digestion was performed at 37°C for 90 minutes followed by 
agarose gel electrophoresis. Restriction buffers were used depending on the 
enzymes. 
Restriction of inserts and vector 
Approximately 7 µg of plasmid pET21b(+) were digested with 40 units Nde I and Xho 
I each in a total volume of 200 µl, whereas 2 µg ELAC1 (PCR product) and 4.8 µg 
ELAC2 (PCR product) were digested with 30 Units Nde I and 20 Units Xho I 
respectively in total volumes of 60 µl each. R+ (Fermentas) served as restriction 
buffer for all 3 reactions which were allowed to proceed at 37°C over night. 
Dephosphorylation of vector 
Digested plasmids (200 µl reaction volume) were supplemented with 2 µl of alkaline 
phosphatase (1 Unit/µl) and dephosphorylated at 37°C for 30 minutes. 
Phenol-chloroform extraction and concentration of nucleic acids 
Purification of nucleic acids was done by phenol extraction: samples were mixed by 
vortexing at full speed for one minute with equal volumes of a mixture of phenol, 
chloroform and isoamyl alcohol (25:24:1). As phases had been separated using a 
bench top microcentrifuge at full speed for two minutes, the upper phases were 
mixed by vortexing with chloroform/isoamyl alcohol to get rid of the phenol, followed 
by centrifugation in order to separate phases. To increase yield double distilled water 
was used for back-extraction. 
Precipitation was performed by adding 0.1 volumes of 10 M ammonium acetate and 
2.5 volumes of pure ethanol. A small amount of LPA (40 µg) served as carrier. Times 
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and temperatures of precipitation varied between 40 minutes at 4°C and over night at 
4°C or -20°C. After centrifugation with a bench top  microcentrifuge at full speed for 
15 minutes the pellets were washed with 70% ethanol, dried at room temperature 
and dissolved in double distilled water. 
Concentrations of DNA were estimated by measuring the absorption at 260 nm 
assuming that 50 ng DNA per µl correspond to an absorption of 1. 
Agarose gel electrophoresis 
Before loading samples onto gel, 0.1 volume of buffer (0.2% bromphenol blue, 0.2% 
xylene cyanol, 10 mM EDTA, 50% sucrose, 20% glycerol) was added. As an 
appropriate gel (0.7 to 1% standard electrophoresis Agarose in 0.5x TBE, 0.5 µg 
ethidium bromide per ml) had been prepared, it was submerged in 0.5x TBE and run 
at 5 V/cm constant voltage. Transillumination with longwavelength ultraviolet light 
was used for visualization of nucleic acids. 
Gel-purification of DNA 
QIAquick Gel Extraction Kit was used for purification of DNA after agarose gel 
electrophoresis. Bands containing nucleic acids of interest were cut out of the gel, 
dissolved in the same volume of QG buffer, heated to 50°C for 10 minutes while 
shaking and trapped on spin columns supplied with the kit using a bench top 
microcentrifuge at full speed for 1 minute. When washing with buffer PE was 
completed, 50 µl of buffer EB was used to elute nucleic acids. 
Concentrations of DNA were estimated by measuring absorption at 260 nm assuming 
that 50 ng DNA per µl correspond to an absorption of 1. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Prior to loading samples onto gel, they were supplemented with 0.25 volumes 5x 
Laemmli buffer and heated up to 95°C for 5 minutes.  Only minigels were used for 
SDS-PAGE. Resolving gels contained 8% acrylamide/bisacrylamide (29:1), 375 mM 
Tris-Cl (pH 8.8) and 0.1% SDS, whereas stacking gels contained 5% 
acrylamide/bisacrylamide (29:1), 125 mM Tris-Cl (pH 6.8) and 0.1% SDS. 
Polymerisation was caused by addition of 0.01 volumes of 10% APS and 0.0006 
(resolving gel) or 0.001 (stacking gel) volumes of TEMED. Gels were run at constant 
voltages: 60 V were used for the entry of samples into gel, whereas 120 V were 
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applied during separation. Electrophoresis was terminated when the bromophenol 
blue had left the bottom of the gel. 
Coomassie staining of SDS-polyacrylamide gels 
In order to visualize proteins gels were usually stained with Coomassie solution 
(0.1% Coomassie Brilliant Blue R-250 (CBR-250), 50% methanol, 10% acetic acid) 
for 30 to 60 minutes and destained afterwards using a solution consisting of 12% 
methanol and 7% acetic acid. 
Alternatively silver staining was performed (see below). 
Silver staining of SDS-polyacrylamide gels 
Gels were fixed in the first solution (50% methanol, 12% acetic acid) for 30 minutes, 
washed twice in the second solution (5% methanol, 6% acetic acid) for 15 minutes 
each, reduced with 1% glutaraldehyde for 30 minutes and washed thrice with double 
distilled water for 10 minutes each. After a final washing step with 32.4 µM DTT for 
30 minutes the gels were stained with 0.1% silver nitrate for 30 minutes, washed 
again with double distilled water and twice with 283 mM sodium carbonate prior to 
developing with 0.0185% formaldehyde for about 3 minutes. When bands were 
visible, the reaction was stopped by replacing the formaldehyde solution with 3% 
acetic acid. 
Alternative the following protocol was used: Gels were fixed in the first solution (50% 
methanol, 5% acetic acid) for 30 minutes, washed in 50% methanol and twice in 
double distilled water for 10 minutes each, sensitized in 0.02% precooled sodium 
thiosulfate for 1 minute and washed twice with double distilled water. As gels had 
been stained with 0.1% silver nitrate for 20 minutes, they were washed twice with 
double distilled water and once with 283 mM sodium carbonate prior to developing 
with 0.037% formaldehyde for about 1 minute. When bands were visible, the reaction 
was stopped by replacing the formaldehyde solution with 3% acetic acid. 
Preparation of competent Escherichia coli 
Bacteria were taken from deep frozen samples and streaked out on LB agar plates 
with appropriate antibiotics and grown at 37°C over  night. As single colonies were 
resuspended in 55 ml SOB each, bacteria were allowed to grow on a shaker at 23°C 
over night. When absorption at 600 nm reached 0.6, 50 ml were transferred into one 
falcon tube each, placed on ice for 10 minutes and centrifuged with 2500g at 4°C for 
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15 minutes. After decantation pellets were resuspended in 16 ml cold TB medium 
and incubated on ice for 10 minutes followed by centrifugation with 2500g at 4°C for 
10 minutes. After decantation pellets were resuspended in 4 ml cold TB medium and 
dimethyl sulfoxide was added to a final concentration of 7% followed by incubation on 
ice for 10 minutes. Aliquots of 200 µl of this suspension were transferred to 
microcentrifuge tubes, shock-frozen in liquid nitrogen and stored at -80°C for further 
use. 
Ligation 
Ligation was performed in 10 µl total volumes using 1 unit of Ligase in the 
appropriate ligation buffer, 52 ng of restricted, dephosphorylated and purified 
pET21b(+), 40 ng ELAC1 (PCR product, restricted and purified) and 98 ng ELAC2 
(PCR product, restricted and purified) respectively, which corresponds to a molar 
ratio of 4:1 of insert to vector. The reactions were allowed to proceed at 16°C over 
night. 
Transformation of competent Escherichia coli 
Usually 50 µl of competent E. coli were transformed with 1 to 10 ng of DNA (25 to 30 
ng if following ligation) and put on ice for 30 minutes. After heat shock at 42°C for 45 
seconds 4 volumes (mostly 200 µl) of SOC were added and the bacteria were 
incubated on a shaker at 37°C for 1 hour. Between 5 0 and 200 µl of that suspension 
were streaked out on LB agar plates supplemented with the appropriate antibiotics 
and grown at 37°C over night. 
Miniprep 
Wizard®Plus SV Minipreps DNAPurification System was used for Miniprep. Usually 
10 ml of bacterial cell suspension were harvested in a microcentrifugation tube using 
5 cycles of centrifugation at full speed for 2 minutes followed by decantation. Pellets 
were resuspended in 250 µl cell resuspension solution, then 250 µl of cell lysis 
solution were added and tubes were inverted 4 times. As 10 µl alkaline protease 
solution were added, tubes were inverted 4 times and reactions allowed to proceed 
at room temperature for 5 minutes followed by addition of 350 µl neutralisation 
solution and inversion of tubes (4 times). In order to maximize yield, tubes were 
centrifuged repeatedly for 10 minutes and supernatants collected each time by 
pipetting them onto spin columns. 
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As DNA was trapped in the stationary phase by centrifugation at full speed for 1 
minute, it was washed twice with 750 µl and 250 µl column wash solution 
respectively. Columns were put on new microcentrifugation tubes and DNA was 
eluted twice using 50 µl nuclease-free water each time resulting in 100 µl purified 
DNA. Concentrations were estimated by measuring the absorption at 260 nm 
assuming that 50 ng DNA per µl correspond to an apsorption of 1. 
Escherichia coli glycerol stock 
Bacterial cultures were grown in LB medium on a shaker at 37°C. During exponential 
phase or sometimes during stationary phase 400 µl were taken and added to 40 µl 
80% glycerol, mixed briefly, shock-frozen in liquid nitrogen and stored at -80°C. 
In vitro transcription and purification of labelled pre-tRNA 
The following components were used for a single in vitro transcription in a total 
volume of 10 µl: 5x in vitro transcription buffer (Fermentas), 1 µl of the restricted 
plasmid phY2/BamHI and phArg2/SacI respectively or hY6 PCR product as template, 
0.5 mM ACGMP-Mix (0.5 mM ATP, 0.5 mM CTP, 0.2 mM GTP, 1 mM GMP), 0.1 mM 
UTP, 0.1 mM (α32P)UTP (10 µCi/µl; 800 Ci/mMol), 0.5 µl RNasin and 20 units of T7 
or 17 units of T3 RNA polymerase (Promega) according to the template used. 
Reactions were allowed to proceed at 40°C for 1 hou r and for another 30 minutes 
after a second addition of 7.5 units of corresponding polymerase. In order to 
terminate the reaction 50 µl “stop-solution” (4 M guanidine thiocyanate, 1 M 
ammonium acetate, 10 mM EDTA) and 2 µl of LPA (20 mg/ml) were added. Nucleic 
acids were precipitated by addition of 150 µl 100% ethanol at 4°C over night. 
After centrifugation with a bench top microcentrifuge at full speed for 15 minutes 
pellets were washed with 450 µl 70% ethanol and allowed to dry at room temperature 
followed by dissolvation in 8 µl buffer F2 (85% formamide, 5% glycerol, 220 mM 
sucrose, 10 mM EDTA, 0.02% bromophenol blue, 0.02% xylene cyanol). Prior to 
loading onto a denaturing, 0.5 mm thick polyacrylamide gel (8% 
acrylamide/bisacrylamide (19:1), 7 M urea in 1x TBE; polymerized by addition of 0.01 
volumes of 10% APS and 0.001 volumes of TEMED) samples were heated up to 
95°C for 5 minutes. Gels were run at 20-25 V/cm con stant voltage in 0.5x TBE. 
When gel electrophoresis was complete, the glass plates were separated and the gel 
exposed to a phosphoimager screen for 1 minute. The bands corresponding to the 
pre-tRNAs were cut out and incubated with 200 µl elution buffer (0.5 M ammonium 
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acetate, 0.1% SDS, 1 mM EDTA) over night. As buffer had been withdrawn, gel 
slices were incubated with 100 µl elution buffer for a second time on a shaker at 35°C 
for a couple of hours (for maximization of yield). Extracts were pooled and phenol 
extraction was performed. 0.01 volumes of LPA (20 mg/ml) and 2.5 volumes of 100% 
ethanol were added in order to precipitate RNA at -20°C over night. 
After centrifugation with a bench top microcentrifuge at full speed for 15 minutes 
pellets were washed with 1 volume of 70% ethanol and allowed to dry at room 
temperature followed by dissolvation in 1 mM EDTA. The amount of EDTA was 
chosen in relation to the emitted radiation, which was estimated by a handheld 
radiation monitor. Pre-tRNAs were stored at -20°C. 
Enzyme assay 
Assays were performed in total volumes of 20 µl each in 30 mM Tris-Cl (pH 7.6), 4.5 
mM MgCl, 30 mM KCl, 20 µg BSA, 5 mM DTT, 0.01 volumes of RNasin, an 
appropriate amount of radiolabelled pre-tRNA and 1 to 3 µl of purified enzyme. 
Additionally 1 mM ATP and 0.1 mM CTP were added to enzyme assays with tRNA 
nucleotidyl transferase. Reactions were allowed to proceed at 25°C for 10 to 30 
minutes. Reaction time and amount of enzyme solution were chosen to match the 
estimated concentrations of purified enzyme in the fractions. In order to terminate 
reactions 50 µl “stop-solution” (4 M guanidine thiocyanate, 1 M ammonium acetate, 
10 mM EDTA) and 2 µl LPA (20 mg/ml) were added. Nucleic acids were precipitated 
with addition of 175 µl 100% ethanol at -20°C over night. 
Denaturing polyacrylamide gel electrophoresis 
After centrifugation with a bench top microcentrifuge at full speed for 15 minutes 
pellets were washed with 300 µl 70% ethanol and allowed to dry at room temperature 
followed by dissolvation in 7 µl of buffer F2 (85% formamide, 5% glycerol, 220 mM 
sucrose, 10 mM EDTA, 0.02% bromophenol blue, 0.02% xylene cyanol). 
Prior to loading onto a denaturing, 0.5 mm thick polyacrylamide gel (8% 
acrylamide/bisacrylamide (19:1), 7 M urea in 1x TBE; polymerized by addition of 0.01 
volumes of 10% APS and 0.001 volumes of TEMED) samples were heated up to 
95°C for 5 minutes. Gels were run at 20-25 V/cm con stant voltage in 0.5x TBE. 
When gel electrophoresis was complete, glass plates were separated and gel 
exposed to a phosphoimager screen at least over night. 
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Expression of recombinant protein 
In order to obtain single colonies transformed E. coli were streaked out on LB agar 
plates supplemented with the appropriate antibiotics and grown at 37°C over night. 
For each expression one colony was resuspended in 6 ml LB supplemented with the 
appropriate antibiotics and grown on a shaker at 37°C over night. These fluid cultures 
were used to inoculate 300 ml LB (+ appropriate antibiotics) and grown on a shaker 
at 37°C for about 2.5 hours. When the absorption at  600 nm reached 0.7, fluid 
cultures were cooled down to 16°C, supplemented wit h 10 µM ZnCl2 and 1 mM IPTG 
and incubated on a shaker at 16°C over night. 
The next day liquid cultures were placed on ice and exact volumes and absorptions 
at 600 nm were determined. After transfer into centrifuge tubes and subsequent 
centrifugation with 3000g at 4°C for 20 minutes sup ernatants were decanted and 
pellets washed with 150 ml buffer (20 mM Tris-Cl (pH 7.5), 100 mM NaCl). 15 ml 
each were transferred into smaller centrifuge tubes and spun down with 3600 rpm at 
4°C for 15 minutes. As supernatants had been decant ed, pellets were shock-frozen 
in liquid nitrogen and stored at -80°C for further use. 
Lysis of bacteria 
Pellets of deep-frozen E. coli were quickly thawed and resuspended in an amount of 
lysis buffer (20 mM Tris-Cl (pH 7.5), 100 mM NaCl, 15% Glycerin, 0.002 volumes 
protease inhibitor, 0.1 mM DTT) corresponding to a calculated absorption of 10. As 
20 µl had been withdrawn as samples for SDS-PAGE analysis, lysis was performed 
in sodium chloride ice baths using a Bandelin Sonopuls HD 70 with standard horn SH 
70 G, MS 73 titanium probe and high frequency generator GM 70. Samples were 
treated with 100% power and 50% cycle thrice for 5 minutes each and allowed to 
cool down for 5 minutes in between. After centrifugation with 20000g at 4°C for 20 
minutes bacterial extracts were transferred with syringes into chilled centrifuge tubes 
on ice by passing through syringe filters (0.22 µm). For SDS-PAGE analysis 20 µl 
samples of extracts and resuspended pellets were taken after lysis. 
Small scale expression 
In order to optimize expression parameters many expression experiments were 
performed with smaller volumes (i. e. < 10 ml) as described above. Usually a single 
colony was resuspended in 1 to 2 ml LB with appropriate antibiotics and grown on a 
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shaker at 37°C over night. A small amount thereof w as used to inoculate < 10 ml LB 
(+ appropriate antibiotics) in sterile culture tubes and grown on a shaker at 37°C for 
about 2 to 3 hours. When the absorption at 600 nm reached 0.5 to 0.8, fluid cultures 
were induced by addition of IPTG (usually 1 mM) and incubated on a shaker at 
different temperatures for various times. 
Afterwards liquid cultures were placed on ice and exact volumes and absorptions at 
600 nm were determined. After transfer into centrifuge tubes and subsequent 
centrifugation with a microcentrifuge at full speed supernatants were decanted. 
Pellets were shock-frozen in liquid nitrogen and stored at -80°C for further use or 
were immediately resuspended in lysis buffer and lysis performed with sonication 
(100% power and 50% cycle, nine times for 10 seconds each with interruptions of 20 
seconds for cooling down) in an ice bath. Alternatively lysis was performed using 
lysozyme (0.5 µg/µl) on a shaker at 4°C for 30 minu tes, 0.5% TritonX-100 and 10 
µg/ml DNase I were added subsequently and allowed to react at 4°C for another 15 
minutes. Centrifugation at 20000g at 4°C for 10 min utes was used for sedimentation 
of cell debris. 
Aliquots of unbroken bacteria, bacterial extract and resuspended cell debris (all 
normalized to cell density and volume) were analysed via SDS-PAGE in order to gain 
information on the optimal parameters for expression of recombinant proteins. 
Immobilized metal ion affinity chromatography 
Buffer A (20 mM Tris-Cl (pH 7.5), 100 mM NaCl, 15% Glycerol, 0.1% Tween-20, 0.1 
mM DTT, 0.001 volumes protease inhibitor) and B (20 mM Tris-Cl (pH 7.5), 100 mM 
NaCl, 15% Glycerol, 0.1% Tween-20, 0.1 mM DTT, 0.001 volumes protease inhibitor, 
500 mM imidazole) were prepared, filtrated (0.22 µm) and degassed. A prepacked 
HisTrap HP 1 ml column (GE Healthcare) was connected to an ÄKTA explorer 
chromatography system and equilibrated with a mixture of 92% buffer A and 8% 
buffer B corresponding to 40 mM imidazole. Meanwhile 2 M imidazole was added to 
the bacterial extract to a final concentration of 40 mM. 
When extract was injected into the chromatography system at a flow rate of 0.25 ml 
per minute using a superloop, collection of 1 ml fractions was started. As injection 
had been completed, the column was washed with a mixture of 80% buffer A and 
20% buffer B (100 mM imidazole, RNase ZS and tRNA ribonucleotidyl transferase) or 
84% A and 16% B (80 mM imidazole, RNase ZL) at a flow rate of 0.7 ml per minute 
  35 
for about 8 column volumes. Elution was caused by switching to a mixture of 40% 
buffer A and 60% buffer B corresponding to 300 mM imidazole at a flow rate of 0.25 
ml per minute for approximately 4 column volumes. As a last step the column was 
washed with 100% buffer B (500 mM imidazole) for 5 column volumes and, as 
collection of fractions had been ceased, with 20% ethanol. 
Selected fractions were analyzed by SDS-PAGE and those containing recombinant 
protein by enzyme assay. 
Storage of recombinant proteins 
Fractions containing recombinant RNase Z were pooled, concentrated using a 
Vivaspin 2 centrifugal device (Vivascience) and diluted by addition of buffer to these 
final concentrations: 20 mM Tris-Cl (pH 7.5), 100 mM NaCl, 50% glycerol, 5 mM 
DTT, 1 mM EDTA, 0.1% Tween-20, 0.1% protease inhibitor and 30 mM imidazole 
(artefact of purification procedure). This enzyme solution was split into 100 µl 
aliquots, some of which were shock-frozen in liquid nitrogen and stored at -80°C, 
whereas others were stored at -20°C. 
Size exclusion chromatography 
After immobilized metal affinity chromatography three fractions of purified RNase ZL 
or RNase ZS were pooled and concentrated using a Vivaspin 2 centrifugal device 
(Vivascience). The resulting concentrate was supplemented with proteins of known 
molecular weight and quarternary structure, which served as molecular weight 
markers: 200 µg chymotrypsinogen, 100 µg ovalbumin, 100 or 200 µg BSA, 200 or 
600 µg aldolase, 200 µg catalase and 100 or 200 µg ferritin. 
A prepacked Superdex 200 10/300 GL chromatography column (GE Healthcare) with 
approximately 24 ml bed volume was connected to an ÄKTA explorer 
chromatography system and equilibrated with buffer (20 mM Tris-Cl (pH 7.5), 100 
mM NaCl, 15% Glycerol, 0.1% Tween-20, 0.1 mM DTT, 0.001 volumes protease 
inhibitor). 100 µl of protein sample were applied at a flow rate of 0.25 ml per minute 
(RNase ZL) or 0.45 ml per minute (RNase ZS). When the absorption at 260 nm began 
to rise, collection of 0.5 ml (RNase ZS) or 0.25 ml (RNase ZL) fractions was started. 
As one bed volume of buffer had passed through the column after injection of 
sample, chromatography was ceased and column washed with 20% ethanol. 
Fractions were analyzed via SDS-PAGE and enzyme assay. 
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Glycerol gradient centrifugation 
Glycerol gradient centrifugations were performed using different salt concentrations 
(100, 150 or 300 mM NaCl) but always the same linear glycerol density gradient (15-
30% glycerol). Further components of the gradients were 20 mM Tris-Cl (pH 7.5), 1 
mM EDTA, 0.1 mM DTT and 0.001 volumes of protease inhibitor. 4 ml gradients were 
generated in Beckman Polyallomer centrifuge tubes (11x60 mm) using a gradient 
mixer connected to a peristaltic pump. 
Mitochondrial extracts or purified recombinant proteins were mixed with equal 
volumes of buffer (20 mM Tris-Cl (pH 7.5), 1 mM EDTA, 0.1 mM DTT, 0.001 volumes 
of protease inhibitor) containing no glycerol but NaCl in such concentrations that the 
resulting concentration was the same as in the glycerol gradient. Microcon centrifugal 
filter devices (50 kD cut-off) were used to concentrate samples to 100 µl. Samples 
were supplemented with four proteins, which served as molecular weight markers: 20 
µg ovalbumin, 20 µg BSA, 40 µg catalase and 120 µg aldolase. As samples were 
layered over glycerol gradients, centrifugation was performed with 485000g at 4°C 
for 14 hours using a swing-out rotor (SW60, Beckman). 
Glycerol gradients were fractionized and fractions (approximately 160 µl each) 
analyzed via SDS-PAGE and enzyme assay. 
Chemical cross-linking 
Buffers of stored enzyme solutions were displaced by repeated dilution with buffer 
(20 mM HEPES-Na (pH 7.6), 150 mM NaCl) and concentration with Microcon 
centrifugal filter devices (50 kD cut-off). 
Chemical cross-linking reactions were performed in 20 µl total volumes using 
approximately 10 µg of purified enzyme and either 0.05% glutaraldehyde, 1 mM BS3 
or 50 mM EDC with 5 mM Sulfo-NHS. Reactions were allowed to proceed for 30 
minutes at room temperature and terminated by addition of 2 µl 1 M Tris-Cl (pH 7.5). 
As 0.25 volumes of 5x Laemmli buffer had been added, samples were heated up to 
70°C for 10 minutes. SDS-PAGE was performed as desc ribed above with the 
exceptions that gradient gels (4-12% acrylamide/bisacrylamide (29:1), polymerized 
by only 0.0075 volumes of APS and 0.0006 volumes of TEMED) were used as 
resolving gels and that the stacking gels contained only 3.5% 
acrylamide/bisacrylamide (29:1). 
Coomassie staining was used for visualization of proteins, as described above. 
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Blue native polyacrylamide gel electrophoresis 
Buffers of stored enzyme solutions were displaced by dilution with 10 mM imidazole 
(pH 7.0) and concentration with Microcon centrifugal filter devices (50 kD cut-off). 
Samples were supplemented with 0.25 volumes of 5x sample buffer (25 mM 
imidazole, 250 mM 6-aminohexanoic acid, 25% Glycerin, 0.5% Coomassie Brilliant 
Blue G250) and approximately 6 µg of protein were loaded onto the gel. Additionally 
3 µg catalase, 5 µg BSA, 5 µg ovalbumin, 10 µg thyroglobulin, 10 µg ferritin and 24 
µg aldolase were loaded as molecular weight markers. 
Gradient gels (8-18% acrylamide/bisacrylamide (29:1)) were used as resolving gels 
containing 25 mM imidazole, 500 mM 6-aminohexanoic acid and polymerization was 
started by addition of 0.008 volumes of APS and 0.0004 volumes of TEMED. 
Stacking gels contained 4% acrylamide/bisacrylamide (29:1), 25 mM imidazole, 500 
mM 6-aminohexanoic acid and were polymerized by addition of 0.01 volumes of APS 
and 0.001 volumes of TEMED. 
Electrophoresis was performed with cathode buffer containing 50 mM tricine, 7.5 mM 
imidazole, 0.02% Coomassie Brilliant Blue G250, pH 7.0, whereas 25 mM imidazole 
(pH 7.0) served as anode buffer. Gels were run at constant voltages: 100 V were 
used for the entry of samples into gel (45 minutes), whereas 200 V were applied 
during separation (90 minutes). Electrophoresis was terminated when Coomassie 
Brilliant Blue had left the bottom of the gel. 
Coomassie staining was used for visualization of proteins, as described above, but 
with a shorter incubation time (10 minutes). 
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Results 
Cloning and Transformation 
The first steps towards expression of recombinant human RNase ZS, RNase ZL and 
tRNA ribonucleotidyl transferase were amplification of genes (“inserts”) and vector, 
the integration of inserts into vector by restriction and ligation and subsequent 
transformation of expression hosts. 
Inserts were amplified by PCR. Agarose gel electrophoresis was performed with a 
small amount thereof to confirm correct base pair length of amplicons. The 
expression vector was amplified by DH5 and recovered via Miniprep. A small amount 
thereof was restricted in order to confirm the correct identity of this plasmid. Bands of 
inserts and digested vector met all expectations (data not shown). 
Vector and inserts (ELAC1, ELAC2 and TRNT1) were restricted by Nde I / Xho I. 
When the vector had been dephosphorylated, proteins were removed by phenol-
chloroform extraction with subsequent concentration by precipitation and resolvation. 
Vector and inserts were purified by agarose gel electrophoresis, gel slices with DNA 
of correct length cut out and DNA was extracted subsequently. Agarose gel 
electrophresis with a small amount thereof confirmed purity of vector and inserts 
(data not shown). 
Vector-insert constructs were ligated and competent DH5 were transformed with 
them. Several colonies of each transformation experiment were selected and tested 
via PCR for successful transformation. Products were visualized by agarose gel 
electrophoresis and successfully transformed DH5 were used to inoculate a liquid 
medium (data not shown). 
Vector-insert constructs were retrieved from DH5 via Miniprep, restrictions of small 
amounts thereof were performed and agarose gel electrophoresis confirmed identity 
and verified correct insertion (data not shown). One clone of each vector-insert 
construct was chosen and sequences of target genes were verified by sequencing 
(data not shown). Thereupon competent host strains for expression were transformed 
with these vector-insert constructs and small scale expression experiments confirmed 
expression of recombinant proteins (data not shown). 
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Optimization of Expression 
At first, only pET21b(+) was used as expression vector and only two genes (ELAC1 
for RNase ZS and ELAC2 for RNase ZL) were inserted into this vector. Vector-insert 
constructs were named pET21-ELAC1 and pET21-ELAC2, respectively. 
BL21(DE3) or Rosetta2(DE3) 
Since human genes had to be expressed in Escherichia coli, the differences between 
bacterial and eukaryal codon usage were expected to be a major problem for 
expression. Therefore two different strains of expression hosts were transformed with 
vector-insert constructs at the beginning: the general expression host BL21(DE3) and 
Rosetta2(DE3). Due to increased expression of seven rare tRNA genes, 
Rosetta2(DE3) is adjusted to the eukaryotic codon usage. 
In order to decide, which host (BL21(DE3) or Rosetta2(DE3)) was better suited for 
expression of each RNase Z, this experiment was performed: As both hosts had 
been transformed with either plasmid (pET21-ELAC1 and pET21-ELAC2), small 
scale expressions were performed throughout different periods of time (0, 1, 2, 3 and 
4 hours) at 30°C using 1 mM IPTG for induction. Whe n bacteria had been harvested 
and lysed, crude lysates were analyzed via SDS-PAGE. Subsequent Coomassie 
staining was used for visualisation. 
It turned out that RNase ZS could be produced by both strains (Figure 13), whereas 
RNase ZL could only be expressed in Rosetta2(DE3) most likely due to increased 
expression of seven rare tRNA genes (Figure 14). 
  40 
Sample BL21(DE3)-pET21-ELAC1 M Rosetta2(DE3)-pET21-ELAC1 
Time 0 h 1 h 2 h 3 h 4 h - 0 h 1 h 2 h 3 h 4 h 
 
Figure 13. Suitability of BL21(DE3) or Rosetta2(DE3) for expression of RNase ZS via pET21b+. SDS-
PAGE of proteomes of BL21(DE3) and Rosetta2(DE3) having expressed RNase ZS at 30°C for 
different periods of time. Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
Sample M BL21(DE3)-pET21-ELAC2 Rosetta2(DE3)-pET21-ELAC2 M 
Time - 0 h 1 h 2 h 3 h 4 h 0 h 1 h 2 h 3 h 4 h - 
 
Figure 14. Suitability of BL21(DE3) or Rosetta2(DE3) for expression of RNase ZL via pET21b+. SDS-
PAGE of proteomes of BL21(DE3) and Rosetta2(DE3) having expressed RNase ZL at 30°C for 
different periods of time. Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
Expression time and temperature 
Expression of both RNases Z had been demonstrated to be possible. The next 
question was, if they could be expressed in a soluble manner, which was not yet 
clear. Enzymes, which are normally in an aqueous environment, need to be folded 
correctly in order to be soluble and enzymatically active. A recommended method to 
increase production of correctly folded, thus soluble recombinant protein is to lower 
expression temperature. This was tested by small scale expression experiments at 
different temperatures for different times: 15°C fo r 5h, 20°C for 4h, 25°C for 3h and 
30°C for 2h. When bacteria had been harvested and l ysed, cell debris were 
sedimented by centrifugation. Extract and resuspended cell debris were analyzed via 
SDS-PAGE. Subsequent Coomassie staining was used for visualisation of 
expression. 
Although the total amount of soluble RNase ZS was only slightly higher at lower 
expression temperatures than at higher expression temperatures, the ratio of soluble 
to insoluble protein was highly increased (Figure 15). Therefore, expression of 
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recombinant proteins at 15°C for a longer period of  time (over night) was chosen. 
Soluble RNase ZL is difficult to recognize on photos, because amounts were often 
very low. Nevertheless, the increase of insoluble RNase ZL at higher temperatures is 
visible (Figure 16). Therefore, it was assumed that expression at 15°C for a longer 
period of time (over night) was favourable for this protein, too. 
Fraction M soluble insoluble 
Temp. [°C] - 15 15 20 25 30 15 15 20 25 30 
Induced - - + + + + - + + + + 
 
Figure 15. Expression and solubility of RNase ZS by BL21(DE3) via pET21b+ at different times and 
temperatures. SDS-PAGE of soluble and insoluble fractions after lysis of BL21(DE3) having grown at 
15°C for 5h (not induced) or having expressed RNase  ZS at 15°C for 5h, at 20°C for 4h, at 25°C for 3h 
or at 30°C for 2h. Marker (PageRuler™ unstained pro tein ladder, Fermentas) served as molecular 
weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
Fraction M soluble insoluble 
Temp. [°C] - 15 15 20 25 30 15 15 20 25 30 
Induced - - + + + + - + + + + 
 
Figure 16. Expression and solubility of RNase ZL by Rosetta2(DE3) via pET21b+ at different times and 
temperatures. SDS-PAGE of soluble and insoluble fractions after lysis of Rosetta2(DE3) having grown 
at 15°C for 5h (not induced) or having expressed RN ase ZL at 15°C for 5h, at 20°C for 4h, at 25°C for 
3h or at 30°C for 2h. Marker (PageRuler™ unstained protein ladder, Fermentas) served as molecular 
weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
Concentration of IPTG 
In order to find out, which effect, if any, the alteration of IPTG concentrations had on 
expression of recombinant proteins, this experiment was performed: small scale 
expressions of RNase ZS and RNase ZL induced by addition of 0.2 mM or 1 mM 
IPTG at 15°C for 5h. When bacteria had been harvest ed and lysed, SDS-PAGE and 
subsequent Coomassie staining were used for visualisation of expression. 
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Because RNase ZL was produced in rather low amounts, it was hard to recognize 
small differences in expression of this recombinant protein, especially on photos. 
Therefore, only the result for the experiment with RNase ZS is shown below (Figure 
17). Addition of 1 mM IPTG resulted in production of more insoluble protein, but 
production of soluble protein was not increased. Therefore, induction by addition of 
0.2 mM IPTG might have been sufficient. Nevertheless, 1 mM IPTG was used later 
on, since it seems to be a standard concentration for expression experiments. 
Moreover, it was considered unreasonable to further hamper expression at 15°C by 
using less IPTG than 1 mM. 
Fraction soluble insoluble 
IPTG 0.2 mM 1 mM 0.2 mM 1 mM 
 
Figure 17. Effect of IPTG concentration on expression of RNase ZS via pET21b+. SDS-PAGE of 
soluble and insoluble fractions after lysis of BL21(DE3) having expressed RNase ZS at 15°C for 5h. 
Induction of expression by addition of 0.2 mM or 1 mM IPTG. All amounts have been normalized to 
cell density and volume at the end of expression experiments. 
Addition of cofactor 
Addition of cofactor can lead to better solubility of recombinant proteins due to better 
folding properties. Since Zn2+ is assumed to be a cofactor for both RNases Z, it was 
tested, whether addition of micromolar amounts can enhance solubility. RNase ZL 
was produced in the lowest amounts of all three recombinant proteins. Furthermore, 
it had a rather unfavourable ratio of soluble to insoluble protein. Therefore, this 
experiment was performed only with this enzyme: a small scale expression induced 
by addition of 1 mM IPTG at 15°C over night with ad dition of 0 µM, 10 µM, 100 µM 
and 1 mM ZnCl2. When bacteria had been harvested and lysed, SDS-PAGE and 
subsequent Coomassie staining were used for visualisation of expression. 
There was no visible positive effect of additional ZnCl2 on solubility of RNase ZL and 
Zn2+ provided by LB medium might have been sufficient (Figure 18). Nevertheless, it 
was considered reasonable to add 10 µM ZnCl2 in further expression experiments of 
both RNases Z, since there was no negative effect on expression until concentrations 
reach 1 mM. 
RNase ZS → 
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Fraction M soluble insoluble 
Induced - - + + + + - + + + + 
ZnCl2 [µM] - 0 0 10 100 1000 0 0 10 100 1000 
 
Figure 18. Effect of additional ZnCl2 on expression of RNase ZL via pET21b+. SDS-PAGE of soluble 
and insoluble fractions after lysis of Rosetta2(DE3) having grown at 15°C over night (not induced 
control) or having expressed RNase ZL at 15°C over night in presence of increasing amoun ts of ZnCl2 
(0 µM, 10 µM, 100 µM or 1 mM). Marker (PageRuler™ unstained protein ladder, Fermentas) served 
as molecular weight standard. All amounts have been normalized to cell density and volume at the 
end of expression experiments. 
ArcticExpress™(DE3) and AE-RARE(DE3) 
Because both RNases Z tended to form inclusion bodies during expression to a 
rather large extent (see Figures 15 and 16), ArcticExpress™(DE3) was tested for its 
ability to produce more soluble protein. RNase ZL could only be expressed in E. coli 
strains with increased expression of seven rare tRNA genes as Rosetta2(DE3). 
Therefore, “AE-RARE(DE3)” was made (ArcticExpress™(DE3) transformed with 
plasmid pRARE2 of Rosetta2(DE3)). These cells were made competent again and 
thereafter transformed with pET21-ELAC2. In order to decide, whether 
ArcticExpress™(DE3) and AE-RARE(DE3) were superior to BL21(DE3) and 
Rosetta2(DE3), small scale expressions induced by addition of 1 mM IPTG were 
performed at 15°C over night. When bacteria had bee n harvested and lysed, SDS-
PAGE and subsequent Coomassie staining were used for visualisation of expression. 
It turned out that ArcticExpress™(DE3) and AE-RARE(DE3) did not produce more 
soluble recombinant protein (only less insoluble protein) but large amounts of 
chaperonins (only Cpn60 is visible in Figures 19 and 20). Moreover, both strains 
needed an additional antibiotic (gentamycin) and grew more slowly. Therefore, they 
were judged inferior to BL21(DE3) or Rosetta2(DE3) and not used for expression of 
recombinant proteins. 
100 kDa 
  85 kDa 
  70 kDa 
 RNase ZL → 
  44 
Fraction M proteome soluble insoluble 
Strain - AE BL AE BL AE BL AE BL 
Induced - - - + + + + + + 
 
Figure 19. Suitability of BL21(DE3) (“BL”) or ArcticExpress™(DE3) (“AE”) for expression of RNase ZS 
via pET21b+. SDS-PAGE of proteomes, soluble and insoluble fractions after lysis of BL21(DE3) or 
ArcticExpress™(DE3) having grown at 15°C over night  (not induced controls) or having expressed 
RNase ZS at 15°C over night. Marker (PageRuler™ unstained p rotein ladder, Fermentas) served as 
molecular weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
Fraction M proteome soluble insoluble 
Strain - AE-R Ros2 AE-R Ros2 AE-R Ros2 AE-R Ros2 
Induced - - - + + + + + + 
 
Figure 20. Suitability of Rosetta2(DE3) (“Ros2”) or AE-RARE(DE3) (“AE-R”) for expression of RNase 
ZL via pET21b+. SDS-PAGE of proteomes, soluble and insoluble fractions after lysis of Rosetta2(DE3) 
or AE-RARE(DE3) having grown at 15°C over night (no t induced controls) or having expressed RNase 
ZL at 15°C over night. Marker (PageRuler™ unstained p rotein ladder, Fermentas) served as molecular 
weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
IMPACT system 
Since expression of RNase ZL by the pET-System yielded the least total protein 
production of all three recombinant proteins and usually a low ratio of soluble to 
insoluble protein, another T7 expression system was tested: the IMPACT system. 
After cloning and transformation procedures of pTYB2-ELAC2 (C-terminal fusion) 
and pTYB12-ELAC2 (N-terminal fusion) small scale expression experiments were 
performed at different temperatures for different times (30°C for 4h, 25°C for 6h, 20 
and 15°C over night) using 1 mM IPTG for induction.  When bacteria had been 
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harvested and lysed, SDS-PAGE and subsequent Coomassie staining were used for 
visualisation of expression. 
RNase ZL expressed via pTYB2 (Figure 21) as well as pTYB12 (Figure 22) seemed 
to form inclusion bodies to an even larger extent compared to RNase ZL expressed 
by pET21b+. Furthermore, the purification was quite disappointing, as tested in a 
small scale experiment (data not shown), and the IMPACT system was therefore 
considered inferior to the pET-system. 
Fraction proteome M soluble insoluble 
Temp. [°C] 15 20 25 30 15 20 25 30 - 15 20 25 30 15  20 25 30 
Induced - - - - + + + + - + + + + + + + + 
 
Figure 21. IMPACT system: Expression of RNase ZL via pTYB2. SDS-PAGE of proteomes, soluble 
and insoluble fractions after lysis of Rosetta2(DE3) having grown (not induced controls) or having 
expressed RNase ZL at 15°C over night, at 20°C over night, at 25°C fo r 6h or at 30°C for 4h. Marker 
(PageRuler™ unstained protein ladder, Fermentas) served as molecular weight standard. All amounts 
have been normalized to cell density and volume at the end of expression experiments. 
Fraction M proteome soluble insoluble 
Temp. [°C] - 15 20 25 30 15 20 25 30 15 20 25 30 15  20 25 30 
Induced - - - - - + + + + + + + + + + + + 
 
Figure 22. IMPACT system: Expression of RNase ZL via pTYB12. SDS-PAGE of proteomes, soluble 
and insoluble fractions after lysis of Rosetta2(DE3) having grown (not induced controls) or having 
expressed RNase ZL at 15°C over night, at 20°C over night, at 25°C fo r 6h or at 30°C for 4h. Marker 
(PageRuler™ unstained protein ladder, Fermentas) served as molecular weight standard. All amounts 
have been normalized to cell density and volume at the end of expression experiments. 
Optimization of lysis 
Although optimization of lysis was actually no optimization of expression, the effect 
on the appearance of proteins (soluble/insoluble) after SDS-PAGE and staining 
procedures seemed to be comparable, because imperfect lysis mimicked bad 
solubility of recombinant proteins. 
Sonication 
Since aqueous solutions of lysozyme seemed to lose activity quite fast when stored 
at 4°C, they had to be prepared freshly for each se t of expression experiments and 
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subsequent lysis of bacteria. In order to overcome this disadvantage lysis by 
sonication was tested and successfully optimized for small scale expression 
experiments (data not shown). Since this method seemed to be more promising for 
expression experiments with larger volumes, it was optimized for this purpose, too. 
As described in “Materials and Methods”, RNase ZS was expressed by BL21(DE3) in 
300 ml LB medium, cells were washed, divided into 1/10 volumes, centrifuged and 
pellets were shock-frozen in liquid nitrogen and stored at -80°C for further use. 
Having thawed one aliquot of this expression experiment, cells were resuspended in 
lysis buffer and lysed by sonication (100% power and 50% cycle) on sodium chloride 
ice bath for as long as 18 minutes. Small samples were taken prior to lysis and every 
three minutes during lysis, which offered enough time for cooling down. SDS-PAGE 
was performed with these samples and Coomassie staining was used for 
visualisation of proteins. 
Although sonication for nine minutes seemed to be enough judged by the photo 
below (Figure 23), 15 minutes (five minutes of sonication for three times alternating 
with five minutes of cooling in between) were used later on. 
Fraction soluble insoluble M 
Time [min] 0 3 6 9 12 15 18 0 3 6 9 12 15 18 - 
 
Figure 23. Optimization of sonication. SDS-PAGE of soluble and insoluble fractions after lysis of 
BL21(DE3) having expressed RNase ZS. Samples were taken after 0, 3, 6, 9, 12, 15 and 18 minutes of 
sonication. Marker (PageRuler™ unstained protein ladder, Fermentas) served as molecular weight 
standard. All amounts have been normalized to cell density and volume at the end of expression 
experiments. 
Composition of lysis buffer 
In order to test, whether recombinant proteins were better soluble in lysis buffer 
containing different amounts of NaCl, this experiment was performed: small scale 
expression of RNase ZS by BL21(DE3) via pET21b+ at 15°C over night using 1 mM 
IPTG for induction. Lysis was performed in buffers containing, among other 
chemicals, different amounts of NaCl (100 mM or 500 mM). SDS-PAGE and 
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subsequent Coomassie staining were used for visualisation of expression and 
solubility of RNase ZS. 
It seemed that RNase ZS was more soluble in the presence of 100 mM NaCl 
compared to 500 mM NaCl (Figure 24). Therefore, 100 mM NaCl was used in further 
lysis buffers for all three recombinant proteins. 
Fraction M proteome soluble insoluble 
Induced - - + + + + + 
NaCl [mM] - - - 100 500 100 500 
 
Figure 24. Effect of different NaCl concentrations on solubility of RNase ZS in lysis buffer. SDS-PAGE 
of proteome, soluble and insoluble fractions after lysis of BL21(DE3) having grown at 15°C over night 
(not induced control) or having expressed RNase ZS. Lysis was performed in buffer containing 100 
mM NaCl or 500 mM NaCl. Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard. All amounts have been normalized to cell density and volume at the end of 
expression experiments. 
Addition of anionic detergents after lysis 
Since anionic detergents such as Tween-20 and TritonX-100 are used for lysis of 
bacteria after treatment with lysozyme due to destabilization of cytoplasmic 
membranes, it was assumed that they may have a positive effect on lysis after 
sonication as well. Therefore, this experiment was performed: small scale expression 
of RNase ZS by BL21(DE3) via pET21b+ at 37°C for 2h using 1 mM  IPTG for 
induction followed by lysis in buffer and subsequent addition of anionic detergents 
(TritonX-100 and Tween-20) in different amounts (0%, 0.2% and 0.5%). SDS-PAGE 
and subsequent Coomassie staining were used for visualisation of expression of 
RNase ZS and for control of lysis. 
Since there was no positive effect of either detergent on lysis after sonication (Figure 
25), both were omitted in further experiments. 
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Fraction M soluble prot insoluble soluble insoluble 
Detergent - TritonX-100 - TritonX-100 Tween-20 Tween-20 
Conc. [%] - 0.0 0.2 0.5 - 0.0 0.2 0.5 0.0 0.2 0.5 0.0 0.2 0.5 
 
Figure 25. Effect of addition of anionic detergents after sonication of BL21(DE3). SDS-PAGE of 
proteome (“prot”), soluble and insoluble fractions after lysis of BL21(DE3) having expressed RNase 
ZS. TritonX-100 or Tween-20 was added in different amounts after sonication. Marker (PageRuler™ 
unstained protein ladder, Fermentas) served as molecular weight standard. All amounts have been 
normalized to cell density and volume at the end of expression experiments. 
Summary of optimization 
Having performed many experiments concerning optimization of expression of 
recombinant proteins, these parameters were chosen finally: 
1. host: BL21(DE3) for expression of tRNA ribonucleotidyltransferase and RNase 
ZS, Rosetta2(DE3) for expression of RNase ZL 
2. system: T7 expression system, vector pET21b(+) 
3. temperature: 15°C during expression 
4. time: expression over night 
5. cofactor: addition of 10 µM ZnCl2 prior to induction 
6. induction: addition of 1 mM IPTG 
7. lysis buffer composition: 20 mM Tris-Cl (pH 7.5), 100 mM NaCl, 15% Glycerin, 
0.002 volumes protease inhibitor, 0.1 mM DTT 
8. lysis: five minutes of sonication on sodium chloride ice bath for three times 
alternating with five minutes of cooling in between 
9. anionic detergents: no addition of Tween-20 or TritonX-100 after lysis 
When the expression of RNase ZS and RNase ZL had been optimized, these 
parameters were adopted for the expression of tRNA ribonucleotidyl transferase as 
well. RNase ZS, RNase ZL and tRNA ribonucleotidyltransferase were subsequently 
expressed as described in “Materials and Methods” in larger amounts. Cells were 
washed, divided into 1/10 volumes, centrifuged and pellets were shock-frozen in 
liquid nitrogen and stored at -80°C for further use . Lysis was performed with 
sonication, usually immediately prior to purification. 
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Purification of recombinant proteins 
Having completed expression experiments, the next step was to purify the 
recombinant proteins. Since all three recombinant proteins were expressed with C-
terminal hexahistidine-tags, purification was done by IMAC using columns prepacked 
with “Ni Sepharose High Performance” connected to an ÄKTA explorer 
chromatography system. 
Optimal conditions for IMAC (primarily concentration of imidazole in chromatography 
buffer during equilibration, loading, washing and elution) are variable depending on 
the protein to be purified and have therefore to be determined individually prior to 
purification. For this purpose an IMAC was done using linear increasing 
concentrations of imidazole for elution after equilibration, loading and washing 
without imidazole. Comparison of SDS-PAGE analysis of fractions and absorption at 
280 nm to corresponding concentrations of imidazole during IMAC allowed 
determination of imidazole concentrations needed for washing and elution of 
recombinant proteins. Imidazole concentrations for equilibration and loading were 
determined independently in subsequent experiments. 
Purifications using IMAC were analyzed by SDS-PAGE of fractions and activities 
were checked by enzyme assays of fractions and subsequent denaturing 
polyacrylamide gel electrophoresis of substrate and processing products. Three 
different radiolabelled human pre-tRNAs were used for enzyme assays. These pre-
tRNAs were endonucleolytically cleaved by RNase ZS or RNase ZL or elongated by 
tRNA ribonucleotidyl transferase in the course of the enzyme assays. 
Purification of RNase ZS 
In order to determine concentrations needed for washing and elution, this IMAC was 
performed: after equilibration, loading and washing without imidazole, linear 
increasing concentrations of imidazole ranging from 0 mM to 500 mM were applied 
during IMAC of RNase ZS. Absorption at 280 nm, conductivity and pressure were 
recorded during chromatography (Figure 26). 
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Figure 26. Determination of imidazole concentration required for washing and elution of RNase ZS. 
Chromatogram of IMAC showing absorption at 280 nm (blue), conductivity (brown), pressure (green) 
and concentration of imidazole (red) ranging from 0 mM to 500 mM imidazole. 
Fractions (1 ml each) were collected during IMAC and subsequently analyzed via 
SDS-PAGE. This facilitated the decision, which imidazole concentrations were apt for 
washing and elution (Figure 27). 
 
Figure 27. Analysis of IMAC of RNase ZS having used a linear imidazole gradient. SDS-PAGE of 
bacterial extract (“Ex”) and selected fractions taken during IMAC. Imidazole concentrations were 
calculated (linear progression). Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard. 
Judged by this results 100 mM seemed to be the optimal concentration of imidazole 
for washing, while 300 mM imidazole were enough for complete elution of RNase ZS. 
Additional chromatography experiments helped to determine imidazole 
concentrations needed for equilibration and during loading of bacterial extract. As it 
turned out a concentration of 40 mM imidazole helped to prevent unspecific binding 
of bacterial proteins during loading and was low enough to enable RNase ZS to bind 
to the chromatography material in the column. Optimized IMACs of RNase ZS were 
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performed using step gradients of imidazole concentrations and yielded highly 
concentrated and satisfactorily purified protein (Figures 28 and 29). 
 
Figure 28. Optimized IMAC of RNase ZS. Chromatogram showing absorption at 280 nm (blue), 
conductivity (brown), pressure (green) and concentration of imidazole (red): a concentration of 40 mM 
imidazole was used for equilibration of column and loading of extract, 100 mM imidazole for washing 
and 300 mM imidazole for elution. In order to ensure that the column was free of proteins after IMAC, 
a concentration of 500 mM imidazole was used after elution. 
Fraction M prot. insol. sol. 5 13 18 19 20 21 
 
Figure 29. Analysis of optimized IMAC of RNase ZS. SDS-PAGE of proteome (“prot.”), insoluble 
(“insol.”) and soluble (“sol.” = bacterial extract) fractions after lysis and fractions collected during IMAC. 
Marker (PageRuler™ unstained protein ladder, Fermentas) served as molecular weight standard. 
When purification of RNase ZS had been completed, enzyme assays were made with 
selected fractions thereof in order to test, whether purified protein showed activity. 
After electrophoresis of assays the gel was incubated with a phosphoimager screen. 
Analysis of the phosphoimager screen confirmed that the 3’ trailer was removed from 
the substrate (radiolabelled nuclear pre-tRNAArg), hence that purified RNase ZS was 
active (Figure 30). 
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Figure 30. Activity of RNase ZS. SDS-PAGE (above) and autoradiogram of denaturing polyacrylamide 
gel electrophoresis (below) of ten consecutive fractions collected during elution of RNase ZS in the 
course of affinity chromatography. Radiolabelled nuclear pre-tRNAArg served as substrate for enzyme 
assays. 
Purification of RNase ZL 
In order to determine concentrations needed for washing and elution, this IMAC was 
performed: after equilibration, loading and washing without imidazole, linear 
increasing concentrations of imidazole ranging from 0 mM to 300 mM were applied 
during IMAC of RNase ZL. Absorption at 280 nm, conductivity and pressure were 
recorded during chromatography (Figure 31). 
 
Figure 31. Determination of imidazole concentration required for washing and elution of RNase ZL. 
Chromatogram of IMAC showing absorption at 280 nm (blue), conductivity (brown), pressure (green) 
and concentration of imidazole (red) ranging from 0 mM to 300 mM imidazole. In order to ensure that 
the column was free of proteins after IMAC, a concentration of 500 mM imidazole was used after 
elution. 
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Fractions (1 ml each) were collected during IMAC and subsequently analyzed via 
SDS-PAGE. This facilitated the decision, which imidazole concentrations were apt for 
washing and elution (Figure 32). 
 
Figure 32. Analysis of IMAC of RNase ZL having used a linear imidazole gradient. SDS-PAGE of 
bacterial extract (“Ex”) and selected fractions taken during IMAC. Imidazole concentrations were 
calculated (linear progression). Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard. 
Judged by this results 80 mM seemed to be the optimal concentration of imidazole 
for washing, while 300 mM imidazole were enough for complete elution of RNase ZL. 
Additional chromatography experiments helped to determine imidazole 
concentrations needed for equilibration and during loading of bacterial extract. As it 
turned out a concentration of 40 mM imidazole helped to prevent unspecific binding 
of bacterial proteins during loading and was low enough to enable RNase ZL to bind 
to the chromatography material in the column. Optimized IMACs of RNase ZL were 
performed using step gradients of imidazole concentrations and yielded highly 
concentrated and satisfactorily purified protein (Figures 33 and 34). 
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Figure 33. Optimized IMAC of RNase ZL. Chromatogram showing absorption at 280 nm (blue), 
conductivity (brown), pressure (green) and concentration of imidazole (red): a concentration of 40 mM 
imidazole was used for equilibration of column and loading of extract, 80 mM imidazole for washing 
and 300 mM imidazole for elution. In order to ensure that the column was free of proteins after IMAC, 
a concentration of 500 mM imidazole was used after elution. 
Fraction M prot. insol. sol. 5 11 17 18 19 20 
 
Figure 34. Analysis of optimized IMAC of RNase ZL. SDS-PAGE of proteome (“prot.”), insoluble 
(“insol.”) and soluble (“sol.” = bacterial extract) fractions after lysis and fractions collected during IMAC. 
Marker (PageRuler™ unstained protein ladder, Fermentas) served as molecular weight standard. 
When purification of RNase ZL had been completed, enzyme assays were made with 
selected fractions thereof in order to test, whether purified protein showed activity. 
After electrophoresis of assays the gel was incubated with a phosphoimager screen. 
Analysis of the phosphoimager screen confirmed that the 3’ trailer was removed from 
the substrate (radiolabelled mitochondrial pre-tRNATyr), hence that purified RNase ZL 
was active (Figure 35). 
 120 kDa 
 100 kDa 
   70 kDa 
   85 kDa 
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Figure 35. Activity of RNase ZL. SDS-PAGE (above) and autoradiogram of denaturing polyacrylamide 
gel electrophoresis (below) of eleven consecutive fractions collected during elution of RNase ZL in the 
course of affinity chromatography. Radiolabelled mitochondrial pre-tRNATyr served as substrate for 
enzyme assays. 
Purification of tRNA ribonucleotidyl transferase 
In order to determine concentrations needed for washing and elution, this IMAC was 
performed: after equilibration, loading and washing without imidazole, linear 
increasing concentrations of imidazole ranging from 0 mM to 300 mM were applied 
during IMAC of tRNA ribonucleotidyl transferase. Absorption at 280 nm, conductivity 
and pressure were recorded during chromatography (Figure 36). 
 RNase ZL → 
 
 
  56 
 
Figure 36. Determination of imidazole concentration required for washing and elution of tRNA 
ribonucleotidyl transferase. Chromatogram of IMAC showing absorption at 280 nm (blue), conductivity 
(brown), pressure (green) and concentration of imidazole (red) ranging from 0 mM to 300 mM 
imidazole. In order to ensure that the column was free of proteins after IMAC, a concentration of 500 
mM imidazole was used after elution. 
Fractions (1 ml each) were collected during IMAC and subsequently analyzed via 
SDS-PAGE. This facilitated the decision, which imidazole concentrations were apt for 
washing and elution (Figure 37). 
 
Figure 37. Analysis of IMAC of tRNA ribonucleotidyl transferase (“TRNT”) having used a linear 
imidazole gradient. SDS-PAGE of bacterial extract (“Ex”) and selected fractions taken during IMAC. 
Imidazole concentrations were calculated (linear progression). Marker (PageRuler™ unstained protein 
ladder, Fermentas) served as molecular weight standard. 
Since the linear imidazole gradient for IMAC of tRNA ribonucleotidyl transferase was 
obviously to steep, conditions for IMAC of this enzyme were chosen based on the 
experiences with RNase ZS and RNase ZL. Therefore a concentration of 100 mM 
imidazole was chosen for washing, while 300 mM imidazole were chosen for elution 
of tRNA ribonucleotidyl transferase. 
50 kDa 
60 kDa 
40 kDa 
70 kDa 
 TRNT → 
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Additional chromatography experiments helped to determine imidazole 
concentrations needed for equilibration and during loading of bacterial extract. As it 
turned out a concentration of 40 mM imidazole helped to prevent unspecific binding 
of bacterial proteins during loading and was low enough to enable tRNA 
ribonucleotidyl transferase to bind to the chromatography material in the column. 
Optimized IMACs of tRNA ribonucleotidyl transferase were performed using step 
gradients of imidazole concentrations and yielded highly concentrated and 
satisfactorily purified protein (Figures 38 and 39). 
 
Figure 38. Optimized IMAC of tRNA ribonucleotidyl transferase. Chromatogram showing absorption at 
280 nm (blue), conductivity (brown), pressure (green) and concentration of imidazole (red): a 
concentration of 40 mM imidazole was used for equilibration of column and loading of extract, 100 mM 
imidazole for washing and 300 mM imidazole for elution. In order to ensure that the column was free of 
proteins after IMAC, a concentration of 500 mM imidazole was used after elution. 
Fraction prot. insol. sol. 3 9 15 16 17 18 M 
 
Figure 39. Analysis of optimized IMAC of tRNA ribonucleotidyl transferase (“TRNT”). SDS-PAGE of 
proteome (“prot.”), insoluble (“insol.”) and soluble (“sol.” = bacterial extract) fractions after lysis and 
fractions collected during IMAC. Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard. 
 50 kDa → 
 60 kDa → 
 70 kDa → 
 TRNT → 
  58 
When purification of tRNA ribonucleotidyl transferase had been completed, enzyme 
assays were made with the purified protein in order to test, whether it showed 
activity. After electrophoresis of assays the gel was incubated with a phosphoimager 
screen. Analysis of the phosphoimager screen confirmed that the 3’ terminal 
nucleotides (CCA) were added to the substrate (radiolabelled mitochondrial pre-
tRNATyr without a 3’ trailer sequence), hence that purified tRNA ribonucleotidyl 
transferase was active (Figure 40). Adenine, however, was not added to the pre-
tRNA quantitatively, if concentration of enzyme was too low. 
TRNT [µg/ml] 0 10 10 1 0.1 
ATP (1 mM) + - + + + 
 
Figure 40. Activity of tRNA ribonucleotidyl transferase. Autoradiogram of denaturing polyacrylamide 
gel electrophoresis having used purified tRNA ribonucleotidyl transferase (“TRNT”) for enzyme 
assays. Radiolabelled mitochondrial pre-tRNATyr served as substrate. Note that 0.1 mM CTP was 
present in every reaction buffer. 
Storage of purified proteins 
Having optimized IMACs of all three recombinant proteins storage conditions were 
tested. Therefore, fractions of purified RNase ZS and RNase ZL were concentrated by 
filtration (as described in “Materials and Methods”) and tenfold diluted by addition of 
six different storage buffers. Final concentrations are shown below. 
• buffer 1: 20 mM Tris-Cl (pH 7.5), 100 mM NaCl, 50% glycerol, 5 mM DTT, 
0.1% Tween-20, 0.1% protease inhibitor and 30 mM imidazole (remaining 
from the purification procedure) 
• buffer 2: as buffer 1, except for 100 mM (NH4)2SO4 instead of NaCl, which was 
reduced to a final concentration of 10 mM remaining from the preceding 
procedures 
• buffer 3: as buffer 1, except for addition of 20 mM MgCl2 
• buffer 4: as buffer 1, except for addition of 1 mg/ml BSA 
• buffer 5: as buffer 1, except for addition of 1 mM EDTA 
• buffer 6: as buffer 1, except for addition of 5% PEG-6000 
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Enzymes were stored at -20°C (liquidly) and at -80° C after being shock-frozen in 
liquid nitrogen. Enzyme assays thereof were made immediately after dilution by 
buffer 1 to 6 and after 5 days of storage (as described in “Materials and Methods”). 
After electrophoresis of assays the gel was incubated with a phosphoimager screen. 
Analysis of the phosphoimager screen showed that addition of 1 mM EDTA (buffer 5) 
was favourable, most probably due to its inhibition of metalloproteases. Ammonium 
sulfate (buffer 2) seemed to conserve a high level of activity, too, if used as salt in 
storage buffers (Figure 41). 
Storage prior to storage stored at -20°C stored at -80°C C 
Buffer 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 - 
 
Figure 41. Activity of differently stored RNase ZL. Autoradiogram of denaturing polyacrylamide gel 
electrophoresis having used purified and differently stored RNase ZL for enzyme assays (“C” is the 
negative control without enzyme). Radiolabelled mitochondrial pre-tRNATyr served as substrate. See 
text for information on buffers 1 to 6. 
Nevertheless, it was still unclear, whether (NH4)2SO4 surpassed NaCl as salt in 
storage buffers or not. Therefore, another experiment was set up with buffer 2 (+ 
addition of 1 mM EDTA) and buffer 5. After electrophoresis of assays the gel was 
incubated with a phosphoimager screen. Since the analysis of the phosphoimager 
screen showed no significant difference between both salts, NaCl was chosen (data 
not shown). Therefore, the final storage buffer was composed of 20 mM Tris-Cl (pH 
7.5), 100 mM NaCl, 50% glycerol, 5 mM DTT, 1 mM EDTA, 0.1% Tween-20, 0.1% 
protease inhibitor and 30 mM imidazole (remaining from the purification procedure). 
Quarternary structure 
The primary objective (expression and purification of three enzymes) was achieved. 
Since these enzymes were active (Figures 30, 35 and 40) and could be stored 
liquidly at -20°C and -80°C retaining most of their  activity, all goals of expression and 
purification had been met. A secondary objective was the analysis of the quaternary 
structure of the RNase Z isoforms. 
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In order to determine, if recombinant proteins RNase ZS and RNase ZL are active as 
mono- or dimers, four different experiments were performed: gel filtration 
chromatography (size exclusion chromatography with aqueous mobile phase), 
glycerol gradient centrifugation, blue native PAGE and chemical cross-linking. The 
latter two were done with recombinant tRNA ribonucleotidyl transferase as well. 
Proteins as chymotrypsinogen (25 kDa), ovalbumin (43 kDa), BSA (67 kDa), aldolase 
(158 kDa), catalase (232 kDa), ferritin (440 kDa) and thyroglobulin (669 kDa) served 
as molecular weight standards. 
Size exclusion chromatography 
Size exclusion chromatographies were performed and selected fractions thereof were 
analyzed via SDS-PAGE and enzyme assays. Four marker proteins were used for 
size exclusion chromatography of purified RNase ZS: chymotrypsinogen, BSA, 
aldolase and ferritin. RNase ZS (monomer: ~41 kDa) seemed to elute prior to BSA 
(67 kDa) but after aldolase (158 kDa), which can be seen as monomer of ~40 kDa in 
SDS-PAGE analysis (Figure 42). This indicated that RNase ZS had a native 
molecular weight between BSA and aldolase and was therefore believed to form 
homodimers. Ferritin (440 kDa), an oligomer consisting of 24 subunits, cannot be 
seen in the SDS-PAGE below (Figure 42), whereas chymotrypsinogen (25 kDa) is 
visible at the lower end of the gel eluting at last. 
Since all marker proteins were stored frozen in aqueous solution and had to be 
thawed prior to use each time, chymotrypsinogen may have been activated by 
unspecific proteolysis forming chymotrypsin. Protease chmyotrypsin could be 
responsible for degradation products of proteins, which can be seen in SDS-PAGE 
analysis as undefined bands. 
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Fraction 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 M 
 
Figure 42. Size exclusion chromatography of RNase ZS. SDS-PAGE (above) and autoradiogram of 
denaturing polyacrylamide gel electrophoresis (below) of 15/14 consecutive fractions collected during 
SEC. Marker (PageRuler™ unstained protein ladder, Fermentas) served as molecular weight standard 
for SDS-PAGE. Radiolabelled nuclear pre-tRNAArg served as substrate for enzyme assays. Note that 
there are many protein bands in SDS-PAGE visible corresponding to proteolytical fragments, which 
may be caused by chymotrypsin, which in turns may have originated from chymotrypsinogen. 
Since resolution of size exclusion chromatography with RNase ZS was rather 
unsatisfying, parameters were changed for SEC with RNase ZL: smaller fractions 
(0.25 ml) were taken and the flow rate was decreased to 0.25 ml per minute. 
Furthermore chymotrypsinogen and ferritin were omitted as marker proteins and 
ovalbumin (43 kDa) and catalase (232 kDa) were used instead. 
Surprisingly recombinant RNase ZL seemed to elute at the same time or even slightly 
earlier as aldolase (158 kDa, can be seen as ~40 kDa monomer in SDS-PAGE 
analysis). This indicated that RNase ZL (monomer: ~92 kDa) had a native molecular 
weight as aldolase or even higher and could therefore be believed to form 
homodimers judged solely by this experiment. Catalase, which can be seen in SDS-
PAGE analysis as monomer of ~58 kDa, peaked at first (approximately at fraction 20 
to 21), followed by RNase ZL (fractions ~22 to 23), whereas aldolase seemed to peak 
at fraction ~23. BSA reached its maximum not until fractions ~26 to 27 and ovalbumin 
eluted at last (maximum at fraction ~31). 
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Figure 43. Size exclusion chromatography of RNase ZL. SDS-PAGE (above) and autoradiogram of 
denaturing polyacrylamide gel electrophoresis (below) of 19/13 consecutive fractions collected during 
SEC. Marker (PageRuler™ unstained protein ladder, Fermentas) served as molecular weight standard 
for SDS-PAGE. Radiolabelled mitochondrial pre-tRNATyr served as substrate for enzyme assays. 
Glycerol gradient centrifugation 
Glycerol gradient centrifugations were performed and selected fractions thereof 
analyzed via SDS-PAGE and enzyme assays. These experiments were performed 
with recombinant RNase ZL and RNase ZS as well as with mitochondrial extracts from 
HeLa cells (native RNase ZL) in different concentrations of NaCl (100, 150 and 300 
mM). 
SDS-PAGE and enzyme assays of glycerol gradient centrifugation of recombinant 
RNase ZL in 100 mM NaCl are shown below (Figure 44). Fractions were taken from 
top to bottom, therefore ovalbumin (43 kDa) can be seen first (mostly fraction ~8) in 
SDS-PAGE analysis followed by BSA (67 kDa), which peaked at fraction 10. 
Recombinant RNase ZL (monomer: ~92 kDa) can be seen in fraction 11 in SDS-
PAGE analysis and mostly in fractions 10 to 12 in enzyme assay analysis. Aldolase 
(158 kDa) can be seen as ~40 kDa monomer in fractions 15 to 16 and catalase (232 
kDa) as ~58 kDa monomer in fractions 20 to 21. Recombinant RNase ZL seemed to 
have a native molecular weight between BSA and aldolase and hence seemed to be 
monomeric judged by glycerol gradient centrifugation. 
 
 
protein peaks: 
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Figure 44. Glycerol gradient centrifugation of RNase ZL. SDS-PAGE (above) and autoradiogram of 
denaturing polyacrylamide gel electrophoresis (below) of 16 consecutive fractions collected after 
glycerol gradient centrifugation. Marker (PageRuler™ unstained protein ladder, Fermentas) served as 
molecular weight standard for SDS-PAGE. Radiolabelled mitochondrial pre-tRNATyr served as 
substrate for enzyme assays. 
In glycerol gradient centrifugation experiments with lower salt concentrations (100 
mM and 150 mM NaCl) recombinant RNase ZL tended to associate forming very 
unstable “dimers”: SDS-PAGE analysis of glycerol gradient centrifugations under 
these conditions showed clearly visible bands of recombinant RNase ZL (as shown 
above) and very thin bands. Clearly visible bands corresponded to a molecular 
weight of ~85 kDa judged by comparison with marker proteins and thin bands 
corresponded to ~140 kDa. These thin bands, however, cannot be seen on the 
photos. In addition, enzyme activities seemed to decrease more slowly with 
increasing number of fraction and hence higher molecular weight compared to 
glycerol gradients with 300 mM NaCl. 
Recombinant RNase ZS (monomer: ~41 kDa) showed a molecular weight 
corresponding to ~80 kDa judged by comparison with marker proteins. In contrast to 
recombinant RNase ZL this result was independent of NaCl concentrations (150 or 
300 mM) and RNase ZS was therefore believed to form homodimers. 
The results of glycerol gradient centrifugations of mitochondrial extracts from HeLa 
cells (native RNase ZL) matched those of recombinant RNase ZL to some extent: 
increasing salt concentrations decreased molecular weight. But native RNase ZL 
seemed to be even heavier than recombinant RNase ZL probably due to other 
50 kDa 
60 kDa 
70 kDa 
85 kDa 
  100 kDa 
40 kDa 
RNase ZL → 
BSA → 
aldolase → 
catalase → 
ovalbumin → 
protein peaks: 
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proteins sticking to it. This was in accordance with the results of Rossmanith and 
Karwan: they performed glycerol gradient centrifugations with the same glycerol 
gradients (15-30% glycerol) as presented within this thesis, but with 150 mM KCl 
instead of NaCl as the main difference. Mitochondrial RNase ZL extracted from HeLa 
cells (called “(mt)3’ pre-tRNase”) seemed to have a molecular weight of ~225 kDa in 
those experiments (Rossmanith and Karwan 1998). 
 
Figure 45. Glycerol gradient centrifugations with different salt concentrations. Information in brackets 
indicate molecular weights corresponding to thin bands of RNase ZL visible in SDS-PAGE (see text for 
further information). 
Blue native PAGE 
Size exclusion chromatography and glycerol gradient centrifugation suggested 
contradictory results for the quarternary structure of recombinant RNase ZL 
(monomer or dimer). Therefore, other methods were used to confirm one result or the 
other. Blue native PAGE was performed using ovalbumin (43 kDa), BSA (67 kDa), 
aldolase (158 kDa), catalase (232 kDa), ferritin (440 kDa) and thyroglobulin (669 
kDa) as molecular weight standards. Recombinant RNase ZS and RNase ZL as well 
as tRNA ribonucleotidyl transferase were tested, whether they showed formation of 
mono- or dimers in blue native PAGE. 
Whereas RNase ZS could not be resolved at all, RNase ZL seemed to have a 
molecular weight similar to catalase (232 kDa). This indicated formation of 
homodimers, but there was a vague band in the range of the monomer (~92 kDa), 
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too. Recombinant tRNA ribonucleotidyl transferase, on the other hand, migrated as a 
monomer (~51 kDa) between ovalbumin and BSA. 
Protein ovalb. BSA aldol. catal. ferritin thyro. ZS ZL TRNT 
kDa 43 67 158 232 440 669    
 
Figure 46. Blue native PAGE of recombinant proteins. Ovalbumin, BSA, aldolase, catalase, ferritin and 
thyroglobulin were used as molecular weight standards. Recombinant proteins: RNase ZS (“ZS”), 
RNase ZL (“ZL”) and tRNA ribonucleotidyl transferase (“TNRT”). Note that RNase ZS could not be 
displayed in blue native PAGE. 
Chemical cross-linking 
Another experiment to confirm formation of di- or oligomers is chemical cross-linking. 
Glutaraldehyde, BS3 and EDC were used for this purpose on recombinant RNase ZS 
and RNase ZL. These proteins were subsequently analyzed via SDS-PAGE. 
Dimers of RNase ZS could clearly be cross-linked by EDC and BS3 and to a lesser 
extent by glutaraldehyde. RNase ZL, on the other hand, showed no formation of 
dimers upon treatment with cross-linkers. Treatment of RNase ZL with glutaraldehyde 
produced a vague smear over a distinct monomer-band, but glutaraldehyde is not a 
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Protein M RNase ZS RNase ZL 
Cross-linker - - glutar. EDC BS3 - glutar. EDC BS3 
 
Figure 47. Chemical cross-linking of recombinant RNases Z. SDS-PAGE of RNase ZS and RNase ZL 
treated with cross-linkers glutaraldehyde, EDC and BS3. Marker (PageRuler™ unstained protein 
ladder, Fermentas) served as molecular weight standard. 
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Discussion 
Codon usage was crucial for expression of RNase ZL 
The main goal of this thesis was the recombinant expression of three human 
enzymes: RNase ZS, RNase ZL and tRNA ribonucleotidyl transferase. It is well known 
that many eukaryotic genes can be expressed in Escherichia coli to a different extent, 
whereas others cannot be expressed at all. Therefore it was assumed prior to cloning 
and transformation procedures that it might be useful to consider two different strains 
of expression hosts: BL21(DE3), the standard expression host for T7 expression 
systems, and Rosetta2(DE3), basically a BL21(DE3) with improved ability of 
expressing eukaryotic genes due to an additional set of rare tRNAs. 
As it turned out, the initial transformation of two different hosts was chosen wisely, 
since RNase ZL could not be expressed in BL21(DE3), but nonetheless in 
Rosetta2(DE3). Most probably this was due to Rosetta’s additional rare tRNAs, which 
aided the expression of eukaryotic genes. Nevertheless, optimization of expression of 
RNase ZL in Rosetta2(DE3) was necessary, since the ratio of soluble to insoluble 
protein was rather low. Recombinant RNase ZS and tRNA ribonucleotidyl transferase, 
on the other hand, could be expressed in the standard expression host BL21(DE3), 
maybe due to a less human-specific codon usage and shorter length of the protein. 
Decrease in the expression rate of RNase Z reduced the 
formation of inclusion bodies 
Formation of inclusion bodies reached rather high levels (50% and higher) during 
expression of RNase ZS and RNase ZL. Since inclusion bodies are insoluble 
aggregates of misfolded proteins, overproduction of recombinant protein seemed to 
be responsible. Recombinant protein can make up half of total cell protein after a few 
hours of expression. This overproduction may lead to formation of inclusion bodies in 
two different ways: high concentrations of folding intermediates might accumulate 
inside the cell, if recombinant proteins are normally folding spontaneously. If they 
need help from the cellular folding machinery, i. e. chaperonins, the bacterial folding 
machinery might become overloaded, which leads to misfolded recombinant proteins. 
Or, in other words, if transcription and thus translation of recombinant proteins, which 
need chaperonins for proper folding, exceed maximal reaction rate (Vmax) of these 
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chaperonins, they will become saturated and, as a consequence, spare proteins will 
become misfolded. These misfolded proteins form inclusion bodies inside the cell due 
to their bad solubility. Therefore the ratio of soluble to insoluble recombinant protein 
can be increased by lowering its transcription and/or translation (Sørensen and 
Mortensen 2005). Recombinant tRNA ribonucleotidyl transferase, on the other hand, 
was almost completely soluble and thus formed almost no inclusion bodies upon 
expression in BL21(DE3). This could be due to a different mode of folding in 
comparison to RNase ZS and RNase ZL. 
Strategies for slowing down expression and thus avoiding formation of inclusion 
bodies include lowering expression temperature and using less IPTG for induction. In 
general, lowering temperature leads to lower reaction rates: proteins are expressed 
more slowly, proteases are less active and growth is reduced significantly. Therefore 
unfolded proteins are less likely to accumulate or overload chaperonins and active 
proteins become less likely degraded by proteases, but expression times have to be 
extended. Additionally, higher temperatures seem to favour aggregation reactions 
over proper folding of proteins, wherefore lowering of expression temperature is 
believed to support folding reactions (Sørensen and Mortensen 2005). The results of 
expression experiments with different temperatures presented within this thesis were 
as expected: lowering expression temperature increased ratio of soluble to insoluble 
recombinant protein, thus minimizing formation of inclusion bodies. 
Using lower concentrations of IPTG for induction is believed to reduce formation of 
inclusion bodies due to slowing down expression of recombinant protein, thereby 
preventing accumulation of unfolded protein and/or keeping chaperonins from 
becoming overloaded. However, the effect of lower concentrations of IPTG for 
induction was not as dramatic as changing expression temperature. There are two 
possible reasons: firstly, lower concentrations of IPTG do not affect aggregation and 
folding reactions directly. Secondly, Escherichia coli are able to take up IPTG actively 
via beta-galactoside permease, wherefore the concentration inside the cell does not 
correlate directly with the concentration outside the cell. Since expression at low 
temperatures seemed very promising in order to minimize formation of inclusion 
bodies and since the effect of lower IPTG concentrations was not very convincing, 
further hampering of expression seemed not reasonable. Therefore 1 mM IPTG was 
used for expression in almost all experiments. 
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Alternative strategies for decreasing inclusion body 
formation during expression of RNase Z were less effective 
Additionally, formation of inclusion bodies may be decreased by adding N- or C-
terminal extensions (i. e. solubility promoting tags), co-expressing chaperonins (e. g. 
GroEL + GroES) or adding cofactor to growth medium. The latter aids proteins, which 
cannot fold properly without their cofactor. 
Co-expression of cold adapted chaperonins 
Since another strain of E. coli (Rosetta2(DE3)) had such a great effect on the 
expression of RNase ZL, it was reasonable that a different strain might reduce 
formation of inclusion bodies as well. Therefore ArcticExpress™(DE3) and AE-
RARE(DE3) were transformed and their expression of recombinant proteins 
compared to BL21(DE3) and Rosetta2(DE3) respectively. ArcticExpress™(DE3) is 
basically a BL21(DE3) expressing additional chaperonins: Cpn10 and Cpn60 of 
Oleispira antarctica (homologues of GroEL and GroES of Escherichia coli). Since 
chaperonin complex GroEL/GroES has reduced activity at low temperatures, their 
cold adapted homologues from a psychrophilic bacterium were expected to 
overcome this problem. But ArcticExpress™(DE3) and AE-RARE(DE3) had several 
disadvantages: firstly, they did not produce more soluble protein, only less insoluble 
compared to BL21(DE3) and Rosetta2(DE3) respectively. Secondly, they expressed 
Cpn10 and Cpn60 in such large amounts that recombinant proteins made up even 
less of total protein. Thirdly, this massive overproduction of chaperonins seemed to 
consume a lot of the cells’ energy, which led to slower growth, to which the challenge 
of an additional antibiotic (gentamycin) might have probably contributed to as well. 
Forthly, pRARE2 (additional tRNA genes) and the plasmid providing chaperonins 
Cpn10 and Cpn60 were not compatible, since they had the same origin of replication 
(P15a of pACYC). Therefore AE-RARE(DE3) was unstable and needed permanent 
selection using chloramphenicol and gentamycin. For all those reasons BL21(DE3) 
and Rosetta2(DE3) were preferred for expression. 
Addition of cofactor 
Some proteins will not fold properly, if they lack their cofactor. All RNase Z are 
believed to need Zn2+ as cofactor for these reasons: Firstly, RNase ZS from Bacillus 
subtilis contains two Zn2+ per dimer judged by crystal structure analysis (Li de la 
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Sierra-Gallay, Pellegrini et al. 2005). Secondly, the crystal structure of RNase ZS from 
Escherichia coli shows two zinc ions in the active site of each monomer and, if metal-
depleted, is not active until Zn2+ is supplemented (Vogel, Schilling et al. 2002) 
(Kostelecky, Pohl et al. 2006). Thirdly, RNase ZS from Arabidopsis thaliana shows 
very high affinity for Zn2+. If it is depleted of metals, nevertheless, its activity can be 
restored by addition of Mg2+, Mn2+, Ca2+ and, of course, Zn2+ (Späth, Canino et al. 
2007). Taken together, this leads to the assumption that all RNase ZS need zinc ions 
and all RNase ZL do probably, too. SDS-PAGE analysis of recombinant RNase ZS 
and RNase ZL expressed via Escherichia coli showed that addition of cofactor Zn2+ 
did not improve folding and hence decrease formation of inclusion bodies 
significantly. Nevertheless, ZnCl2 was added in micromolar amounts (10 µM) to 
Escherichia coli expressing recombinant RNase ZS or RNase ZL, although 
concentration of Zn2+ present in LB medium might have been sufficient. 
Alternative expression system 
Since the IMPACT system was available, it was tested, whether it might provide 
better expression or solubility of RNase ZL. Expression of intein-tagged RNase ZL 
was surprisingly high judged by SDS-PAGE, although these tags are rather big. 
RNase ZL tagged at the C-terminus was only expressed at 25°C and above, but N-
terminally tagged RNase ZL was expressed at all temperatures (15 to 30°C) in rather 
high amounts. Unfortunately, all intein-tagged RNase ZL variants seemed to be 
insoluble, i. e. they formed inclusion bodies. Nevertheless, it was tried to purify intein-
tagged RNase ZL, because even small amounts of soluble protein (undetectable by 
SDS-PAGE) might have gotten concentrated in the course of affinity 
chromatography. But the results of some small scale expression and purification 
experiments showed that RNase ZL remained undetectable via SDS-PAGE, even 
after affinity chromatography procedures. Furthermore, self-cleavage of fusion 
protein (intein-RNase ZL) was quite inefficient judged by a small experiment and 
reached satisfying levels not under 16°C. Leaving a  protein, which is otherwise 
handled with extreme care, at 16°C for a couple of hours seemed quite 
unreasonable, moreover. 
Using alternative tags might improve solubility of recombinant proteins, as reported 
for tags as GST, Trx or NusA. Since these tags are rather big, they need to be 
removed from the protein by proteases after purification procedures. Faced with the 
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unsatisfying efficiency of self-cleavage by intein it was considered unreasonable to 
use other proteases on recombinant proteins, although they might have been more 
efficient. Hexahistidine-tags, on the other hand, offer some advantages: firstly, 
purification procedures will be rather simple, if removal of tag is not necessary. 
Secondly, purification by IMAC is very efficient and leads to well concentrated 
recombinant proteins. Thirdly, expression of hexahistidine-tagged RNase ZS, RNase 
ZL and tRNA ribonucleotidyl transferase yielded enough soluble protein, which could 
be enriched in the course of affinity chromatography. For all those reasons 
expression with pET-system using the hexahistidine tags was preferred over the 
IMPACT system. 
Imperfect lysis mimicked bad solubility of recombinant 
proteins 
As first expression experiments were done, lysis of bacteria was performed using 
lysozyme. Therefore, an aqueous solution of this enzyme was made, kept on ice and 
stored at 4°C after first use. As it turned out, th is enzyme lost its activity quite fast 
under these conditions. 
As described in “Materials and Methods” crude lysates were centrifuged for 
separating cell debris from extract. This procedure made imperfect lysis mimic 
formation of inclusion bodies, since unbroken bacteria sedimented as well taking 
enclosed recombinant proteins with them. Therefore, solubility of recombinant 
proteins seemed to get worse each time, when the same aqueous solution of 
lysozyme was used after storage at 4°C for a couple  of days. Soon it was realized 
that bad lysis was to blame for this effect and alternatives were sought to preparing 
lysozyme freshly each time. Since all devices needed for sonication were available, 
sonication was tested and optimized for small bacterial suspensions (0.5 to 1 ml) as 
well as larger ones (6 to 11 ml). 
Because formation of inclusion bodies was judged by SDS-PAGE, it could not be 
excluded that remaining insoluble recombinant protein was in reality soluble but still 
enclosed by its host, when the crude lysate was centrifuged. Therefore, experiments 
concerning composition of lysis buffer and addition of anionic detergents after lysis 
were done. Anionic detergents seemed to have no effect on lysis after sonication, 
which is quite reasonable considering the difference between lysis by lysozyme and 
sonication: while lysozyme destroys the cell wall leaving the cell membrane 
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vulnerable to attack by detergents, sonication causes microscopic bubbles inside the 
cell “exploding” it from the inside. Therefore, anionic detergents are necessary for 
lysis with lysozyme, while they have no (or little) effect after lysis by sonication. That 
is why no anionic detergents were added after lysis by sonication in further 
experiments. 
Composition of lysis buffer was mainly based on conventional wisdom (20 mM Tris-Cl 
(pH 7.5), 15% Glycerin, 0.002 volumes protease inhibitor, 0.1 mM DTT) and only 
concentration of NaCl was subjected to further investigation. A concentration of 100 
mM NaCl seemed to get more RNase ZS dissolved in lysis buffer than 500 mM. 
Therefore a concentration of 100 mM sodium chloride was chosen for all lysis buffers 
in further experiments. 
IMAC: Step elution causes concentration of recombinant 
protein 
Immobilized metal ion affinity chromatography (IMAC) was used for single-step 
purification of histidine-tagged proteins. Furthermore, it had a pleasant side effect: 
concentration of recombinant protein. 
Usually, imidazole is used for elution, which displaces the His-tag and hence the 
whole protein from an immobilized nickel cation in a competitive manner. This means 
that different concentrations of imidazole have different effects: while high 
concentrations cause instant elution of recombinant proteins, low concentrations just 
remove unspecifically bound proteins and all graduations are possible in between. 
Therefore step gradients of imidazole concentration can be applied as well as linear 
gradients in the course of affinity chromatography. 
Linear gradients offer the possibility of determining the imidazole concentrations 
necessary for washing and elution of recombinant protein. This is especially useful, 
since different histidine-tagged proteins need different imidazole concentrations for 
these steps. Therefore linear gradients of imidazole concentrations are usually 
applied during first affinity chromatography of a newly expressed recombinant protein 
in order to gain information on concentrations needed for washing and elution. When 
these parameters for affinity chromatography of a recombinant protein are known, 
step gradients can be used instead. Nevertheless, these parameters should be 
balanced between purity (higher imidazole concentration during loading and 
washing) and yield (lower imidazole concentration during loading and washing) 
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depending on further use of purified proteins. Since recombinant RNase ZS, RNase 
ZL and tRNA ribonucleotidyl transferase were intended for use as parts of an in vitro 
tRNA-processing system in order to study pathogenic mutations of mitochondrial 
tRNAs, it was assumed that small impurities of bacterial proteins would not hamper 
their enzymatic activities or alter reaction products in significant amounts. Therefore, 
yield seemed to be more important than absolute purity, when concentrations for 
washing and elution were determined for each protein after first purifications using 
linear gradients of imidazole. 
Step gradients offer two advantages: firstly, imidazole concentrations at any point of 
affinity chromatography are clearly defined, since they are not changing anytime. 
Therefore the purified protein will be in a buffer of well known composition. Secondly, 
increasing the imidazole concentration at once for elution (“step elution”) causes 
(almost) all recombinant proteins to elute at once, thus concentrating them in very 
few fractions. This was impressively demonstrated by the optimized affinity 
chromatography of tRNA ribonucleotidyl transferase, which was concentrated in 
almost one single fraction (1 ml) and with an astonishing purity. Step elution was also 
used in the course of affinity chromatography of RNase ZS and RNase ZL. 
In conclusion, immobilized metal ion affinity chromatography using a chromatography 
system (ÄKTA explorer) proved to be fast, easy to handle and provided surprisingly 
good results for a single-step purification procedure. 
Recombinant proteins were enzymatically active 
Another main goal of the primary objective of this diploma thesis was that the 
recombinant proteins RNase ZS, RNase ZL and tRNA ribonucleotidyl transferase had 
to be enzymatically active. Therefore enzyme assays were performed using 
radiolabelled pre-tRNAs as substrates. These experiments were performed 
immediately after purification procedures (IMAC) and after some time of storage. The 
results of this assays showed that the recombinant proteins were enzymatically 
active immediately after IMAC as well as after some time of storage under different 
conditions (fluid at -20°C or frozen at -80°C). It has to be mentioned, however, that 
RNase ZL seemed to be more active than RNase ZS in all these experiments, but 
activity depends on the substrate used for assays. Since no special experiments 
concerning enzyme kinetics were performed, no clear statement can be made on the 
differences in enzyme activity between RNase ZS and RNase ZL. 
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However, after all preceding procedures (heterologous expression, lysis, purification 
and storage) all recombinant proteins performed their intended enzymatic reactions 
well. Therefore, they could be used as parts of an in vitro tRNA-processing system so 
as to study pathogenic mutations of mitochondrial tRNAs. This meant that all goals of 
expression and purification had been met. 
Human RNase ZS is a homodimer 
Crystal structures of RNase ZS from Bacillus subtilis, Escherichia coli and 
Thermotoga maritima suggest homodimeric proteins. Therefore all other orthologues 
of RNase ZS are believed to form homodimers as well (Ceballos and Vioque 2007). 
This assumption was supported by various experiments with human recombinant 
RNase ZS, at least for this particular protein. In the course of this thesis four different 
methods were used to address the quaternary structure of human RNase ZS: size 
exclusion chromatography, glycerol gradient centrifugation, blue native PAGE and 
chemical cross-linking. With the exception of blue native PAGE, in which recombinant 
RNase ZS could not be displayed, all other three experiments indicated a dimeric 
quaternary structure for this protein. 
In size exclusion chromatography recombinant RNase ZS (monomer: ~41 kDa) had a 
molecular weight between aldolase (158 kDa) and BSA (67 kDa). Since recombinant 
RNase ZS was purified and remaining impurities (bacterial proteins) were negligible 
and therefore not reasonable as interaction partners, this means that recombinant 
RNase ZS could be assumed to form homodimers judged by this experiment. 
Molecular weight of recombinant RNase ZS was calculated based on results of 
glycerol gradient centrifugation: approximately 80 kDa. In contrast to RNase ZL this 
result was independent of salt concentration used in buffer (150 or 300 mM NaCl). 
This finding clearly supported the assumption that recombinant RNase ZS forms 
stable homodimers. 
Chemical cross-linking was performed using three different cross-linkers: 
glutaraldehyde, EDC and BS3. All three of them were able to covalently cross-link 
recombinant RNase ZS as shown via SDS-PAGE. This was another evidence for 
recombinant RNase ZS being a homodimer, because only adjacent proteins can be 
cross-linked by these chemicals. 
Summed up, all results indicated the formation of homodimers for recombinant 
RNase ZS. Since it was reported that hexahistidine-tags can cause dimerization at 
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least for one DNA binding protein called π30.5, the results for recombinant RNase ZS 
can only be assumed to be true for native RNase ZS with some caution (Wu and 
Filutowicz 1999). To eliminate this problem, the same experiments could be made 
with purified native RNase ZS, a two-hybrid screening could be performed or the 
crystal structure of the native protein could be determined. 
Quaternary structure of RNase ZL is still unclear 
Although it is widely assumed that all RNases ZL are active as monomers, there 
seems to be no experimental evidence to support this assumption. Basically their 
domain structure, which resembles a covalently linked dimer, is taken as a hint for 
being a monomer. This domain structure is believed to have arisen by gene 
duplication of RNase ZS and hence is taken as reference of its origin assuming that 
RNase ZS and RNase ZL are paralogues. The structure of RNase ZL was predicted 
by Redko et al. using data of crystal structures of RNase ZS from Bacillus subtilis, 
Escherichia coli and Thermotoga maritima. This structure shows a monomer capable 
of processing one tRNA at a time (Redko, Li de la Sierra-Gallay et al. 2007). 
In the course of this thesis some experiments were performed to contribute to this 
ongoing debate: size exclusion chromatography, glycerol gradient centrifugation, 
blue native PAGE and chemical cross-linking. Most interestingly, two experiments 
confirmed a monomeric form of RNase ZL, whereas the other two contradicted this 
current opinion and showed formation of dimers. 
In size exclusion chromatography recombinant RNase ZL (monomer: ~92 kDa) 
seemed to have a molecular weight as aldolase (158 kDa) or even slightly higher. 
Since recombinant RNase ZL was purified and remaining impurities (bacterial 
proteins) were negligible and therefore not reasonable as interaction partners, this 
means that recombinant RNase ZL could be assumed to form homodimers judged by 
this experiment. 
Molecular weight of recombinant RNase ZL was also calculated based on results of 
glycerol gradient centrifugation: approximately 85 kDa. In contrast to recombinant 
RNase ZS this result was dependent on salt concentration used in buffer (100, 150 or 
300 mM NaCl): if low salt concentrations were used (100 or 150 mM NaCl), a slight 
second peak appeared correlating to a molecular weight of ~140 kDa. This peak 
disappeared, if 300 mM NaCl were used in the buffer. Since dimers should normally 
be stable in 300 mM NaCl, this result supported the current opinion on RNase ZL 
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being a monomer. Glycerol gradient centrifugations were also performed using 
mitochondrial extracts containing native human RNase ZL. Calculated molecular 
weight at low salt concentration seemed even higher, but decreased with increasing 
salt concentrations: 200 kDa (100 mM NaCl), 160 kDa (150 mM NaCl) and 110 kDa 
(300 mM NaCl). This suggested one or more interaction partners in the mitochondrial 
extract rather than formation of homodimers. 
Blue native PAGE, on the other hand, showed formation of homodimers. 
Recombinant RNase ZL seemed to have a molecular weight as catalase (232 kDa) 
judged by this experiment, although there was a slight band correlating to a 
monomeric form. Strangely recombinant RNase ZS could not be displayed in blue 
native PAGE and tRNA ribonucleotidyl transferase seemed to be a monomer 
contradicting current opinion of being a covalently linked homodimer. Maybe its 
linkage (a disulfide bond) became reduced in the course of the gel electrophoresis. 
Chemical cross-linking was performed using three different cross-linkers: 
glutaraldehyde, EDC and BS3. All three of them were not able to cross-link 
recombinant RNase ZL covalently as shown via SDS-PAGE, although there seemed 
to be a light smear in the range of a dimeric RNase ZL if treated with glutaraldehyde. 
But since glutaraldehyde is no specific cross-linker and side reactions are likely, it 
can be claimed that recombinant RNase ZL could not be cross-linked by these three 
chemicals. Nevertheless, it has to be mentioned that failure of cross-linking is no 
evidence for a monomeric protein. 
Taken together, no clear statement could be made, whether recombinant RNase ZL 
was active as mono- or dimer. Maybe it just aggregated and formed loose “dimers” in 
the absence of any other interaction partner depending on the surrounding 
conditions. Furthermore, reported effects of hexahistidine-tags being capable of 
conveying dimerization complicate any statement on native RNase ZL derived from 
recombinant RNase ZL (Wu and Filutowicz 1999). To eliminate this problem, the 
same experiments could be made with purified native RNase ZL, a two-hybrid 
screening could be performed or the crystal structure of the native protein could be 
determined. 
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Abstract 
All tRNAs are transcribed as immature precursors, which have to be processed at the 
3’ and at the 5’ end. This diploma thesis is about the enzymes maturating the 3’ end 
in humans: RNase Z (two isozymes: RNase ZS and RNase ZL) removes extra 
nucleotides from the 3’ end and tRNA ribonucleotidyl transferase adds and/or repairs 
the sequence CCA subsequently. Primary objective of this thesis was the 
recombinant expression of these proteins in Escherichia coli and their purification in 
order to use them as parts of an in vitro tRNA-processing system so as to study 
pathogenic mutations of mitochondrial tRNAs. 
When bacterial expression was achieved, it was optimized to minimize formation of 
inclusion bodies. As a result, the pET-system (Novagen) was used for expression of 
C-terminally hexahistidine-tagged versions of all three proteins. RNase ZS and tRNA 
ribonucleotidyl transferase were expressed via BL21(DE3) at low temperatures 
(~15°C) over night using 1 mM IPTG for induction an d RNase ZL was expressed via 
Rosetta2(DE3) under the same conditions. 
Purification of recombinant proteins was done via affinity chromatography using an 
ÄKTA explorer chromatography system. The procedure was optimized using step 
gradients of imidazole concentration for loading, washing and elution. Proteins were 
checked for activity and subsequently stored in buffer containing 50% glycerol at -
20°C or frozen at -80°C. 
Secondary objective was gaining some information on quaternary structure of both 
RNases Z. Four different methods were used: size exclusion chromatography, 
glycerol gradient centrifugation, blue native PAGE and chemical cross-linking. RNase 
ZS seemes to be a homodimer judged by size exclusion chromatography, glycerol 
gradient centrifugation and chemical cross-linking. The quaternary structure of 
RNase ZL, on the other hand, is still unclear. Whereas size exclusion 
chromatography and blue native PAGE suggested a homodimer, glycerol gradient 
centrifugation appeared to indicate a monomer or a salt-labile homodimer depending 
on the buffer conditions used. Chemical cross-linking failed. 
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Zusammenfassung 
Alle tRNAs werden als unreife Vorläufer transkribiert, die an ihren 3’- und 5’-Enden 
prozessiert werden müssen. Diese Diplomarbeit beschäftigt sich mit den Enzymen, 
die für die Reifung der 3’-Enden beim Menschen zuständig sind: RNase Z (zwei 
Isozyme: RNase ZS und RNase ZL) entfernt überzählige Nukleotide am 3’-Ende und 
tRNA-Ribonukleotidyltransferase addiert und/oder repariert anschließend die 
Sequenz CCA. Primäres Ziel dieser Arbeit war die rekombinante Expression dieser 
Proteine in Escherichia coli und deren Reinigung, um sie als Teile eines in vitro 
Prozessierungssystems zur Erforschung pathogener Mutationen von tRNAs zu 
benutzen. 
Nach erfolgreicher bakterieller Expression wurde diese optimiert, um die 
Einschlusskörperbildung zu minimieren. In der Folge wurde das pET-System 
(Novagen) für die Expression von C-terminal mit einem Hexahistidintag versehenen 
Versionen aller drei Proteine benutzt. RNase ZS und tRNA-
Ribonukleotidyltransferase wurden mittels BL21(DE3) bei niedrigen Temperaturen 
(~15°C) über Nacht unter Verwendung von 1 mM IPTG z ur Induktion exprimiert und 
RNase ZL wurde mittels Rosetta2(DE3) unter den selben Bedingungen exprimiert. 
Die Reinigung der rekombinanten Proteine erfolgte per Affinitätschromatographie, 
wobei ein „ÄKTA explorer“ Chromatographiesystem benutzt wurde. Die Prozedur 
wurde optimiert mittels Stufengradienten der Imidazolkonzentration für Laden, 
Waschen und Eluieren. Die Proteine wurden auf Aktivität getestet and anschließend 
in einem Buffer mit 50% Glycerin auf -20°C oder gef roren auf -80°C gelagert. 
Sekundäres Ziel war die Erlangung von Information bezüglich der Quartärstruktur 
beider RNase Z. Vier verschiedene Methoden wurden angewandt: Gelfiltration, 
Glyceringradientenzentrifugation, blue native PAGE und chemisches Cross-linking. 
RNase ZS schien ein Homodimer zu sein, wofür Gelfiltration, 
Glyceringradientenzentrifugation und chemisches Cross-linking sprachen. Im 
Gegensatz dazu ist die Quartärstruktur von RNase ZL weiterhin unklar. Während 
Gelfiltration und blue native PAGE ein Homodimer suggerierten, schien die 
Glyceringradientenzentrifugation ein Monomer oder ein salzlabiles Homodimer zu 
zeigen abhängig von den verwendeten Bufferbedingungen. Chemisches Cross-
linking schlug fehl. 
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